<!DOCTYPE article
 PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.2 20190208//EN" "JATS-archivearticle1.dtd">
<article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="preprint"><?all-math-mml yes?><?use-mml?><?origin ukpmcpa?><front><journal-meta><journal-id journal-id-type="nlm-ta">bioRxiv</journal-id><journal-title-group><journal-title>bioRxiv : the preprint server for biology</journal-title></journal-title-group><issn pub-type="epub">2692-8205</issn></journal-meta><article-meta><article-id pub-id-type="manuscript">EMS207079</article-id><article-id pub-id-type="doi">10.1101/2025.07.01.662540</article-id><article-id pub-id-type="archive">PPR1046348</article-id><article-version-alternatives><article-version article-version-type="status">preprint</article-version><article-version article-version-type="number">1</article-version></article-version-alternatives><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>Autism-associated oxysterol regulates GABAergic neurogenesis and subtype fates</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Cruz-Santos</surname><given-names>Maria</given-names></name><xref ref-type="aff" rid="A1">1</xref><xref ref-type="aff" rid="A3">3</xref></contrib><contrib contrib-type="author" equal-contrib="yes"><name><surname>Kidd</surname><given-names>Ethan</given-names></name><xref ref-type="aff" rid="A1">1</xref><xref ref-type="aff" rid="A3">3</xref></contrib><contrib contrib-type="author" equal-contrib="yes"><name><surname>Li</surname><given-names>Zongze</given-names></name><xref ref-type="aff" rid="A1">1</xref><xref ref-type="aff" rid="A2">2</xref></contrib><contrib contrib-type="author"><name><surname>De La Fuent</surname><given-names>Daniel Cabezas</given-names></name><xref ref-type="aff" rid="A1">1</xref><xref ref-type="aff" rid="A2">2</xref></contrib><contrib contrib-type="author"><name><surname>Davies</surname><given-names>Sara</given-names></name><xref ref-type="aff" rid="A2">2</xref></contrib><contrib contrib-type="author"><name><surname>Vinh</surname><given-names>Ngoc-Nga</given-names></name><xref ref-type="aff" rid="A2">2</xref></contrib><contrib contrib-type="author"><name><surname>Fjodorova</surname><given-names>Marija</given-names></name><xref ref-type="aff" rid="A1">1</xref><xref ref-type="aff" rid="A2">2</xref></contrib><contrib contrib-type="author"><name><surname>Li</surname><given-names>Meng</given-names></name><xref ref-type="aff" rid="A1">1</xref><xref ref-type="aff" rid="A2">2</xref><xref ref-type="aff" rid="A3">3</xref><xref ref-type="corresp" rid="CR1">#</xref></contrib></contrib-group><aff id="A1"><label>1</label>Neuroscience and Mental Health Innovation Institute</aff><aff id="A2"><label>2</label>Division of Psychiatry and Clinical Neuroscience, School of Medicine</aff><aff id="A3"><label>3</label>School of Bioscience, <institution-wrap><institution-id institution-id-type="ror">https://ror.org/03kk7td41</institution-id><institution>Cardiff University</institution></institution-wrap></aff><author-notes><corresp id="CR1"><label>#</label> Corresponding author, <email>lim26@cf.ac.uk</email></corresp></author-notes><pub-date pub-type="nihms-submitted"><day>11</day><month>07</month><year>2025</year></pub-date><pub-date pub-type="preprint"><day>03</day><month>07</month><year>2025</year></pub-date><permissions><ali:free_to_read/><license><ali:license_ref>https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This work is licensed under a <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">CC BY 4.0 International license</ext-link>.</license-p></license></permissions><abstract><p id="P1">Distorted GABAergic neurodevelopment is believed to underscore cortical network dysfunction that lies at the heart of neurodevelopmental disorders (NDD) such as autism and schizophrenia. GABAergic neuron diversity is sculptured by cortical environmental cues during protracted postmitotic differentiation. However, the mechanism by which the NDD environment influences GABAergic neuronal development remains largely unknown. Oxysterols are oxidized metabolites of cholesterol that can interact with developmental signaling pathways. Using an iPSC model recapitulating human forebrain GABAergic neuron development and single-cell transcriptomic profiling, we show that 24S, 25-epoxysterol, an NDD-affected oxysterol highly enriched in the fetal brain, promotes neurogenesis, and disturbs the composition of GABAergic neuronal subtypes. Moreover, pharmacological and genetic interrogation identified the liver X receptor as a regulatory pathway mediating the action of 24S, 25-epoxysterol. These findings provide insights into the roles of cholesterol metabolism in neuronal development and a potential mechanism by which dysregulated brain oxysterols contribute to the pathogenesis of NDD.</p></abstract><kwd-group><kwd>human pluripotent stem cells (hPSCs)</kwd><kwd>neuropsychiatric disorders</kwd><kwd>neurogenesis</kwd><kwd>oxysterol</kwd><kwd>liver X receptor</kwd></kwd-group></article-meta></front><body><sec id="S1" sec-type="intro"><title>Introduction</title><p id="P2">Gamma-aminobutyric acid (GABA)-releasing inhibitory neurons are a highly diverse population of cells that play a critical role in maintaining neural circuit functions and modulating complex behaviors<sup><xref ref-type="bibr" rid="R1">1</xref>,<xref ref-type="bibr" rid="R2">2</xref></sup>. Dysfunction of these neurons leads to an excitatory-inhibitory imbalance that lies at the heart of neurodevelopmental disorders (NDDs), such as schizophrenia, autism spectrum disorders, and epilepsy<sup><xref ref-type="bibr" rid="R1">1</xref>, <xref ref-type="bibr" rid="R3">3</xref>–<xref ref-type="bibr" rid="R5">5</xref></sup>. Disturbances in GABAergic neuron function have also been linked to altered network activity and cognitive dysfunction in Alzheimer’s disease<sup><xref ref-type="bibr" rid="R6">6</xref></sup>. A growing body of genomics studies has demonstrated that NDD risk variants are over-represented in GABAergic neuron transcripts and open chromatin and are already evident in fetal development<sup><xref ref-type="bibr" rid="R7">7</xref>–<xref ref-type="bibr" rid="R11">11</xref></sup>. These findings suggest an early developmental etiology of these conditions.</p><p id="P3">24S,25-epoxycholesterol (24S,25-EC) is the most prevalent oxysterol in the fetal brain and plays a critical role in midbrain dopamine neurogenesis<sup><xref ref-type="bibr" rid="R12">12</xref>–<xref ref-type="bibr" rid="R17">17</xref></sup>. We recently reported that 24S,25-EC production is altered in autism iPSC-derived cortical cells, leading to either a delay or accelerated cortical neuron differentiation, depending on the direction of the 24S,25-EC level change caused by distinct disease genetic alterations<sup><xref ref-type="bibr" rid="R18">18</xref></sup>. While originating from the medial ganglionic eminence (MGE), forebrain GABAergic interneurons specify into diverse subtypes in the cortex and striatum, where the local environment sculptures this process. Moreover, 24S,25-EC can activate hedgehog signaling by binding to its signal transducer smoothened<sup><xref ref-type="bibr" rid="R19">19</xref></sup>. Together, these findings raise the question of whether 24S,25-EC modulates MGE neural progenitor induction and their differentiation into MGE-derived neuronal subtypes and how changes in its production in pathological brain environments disrupt this process.</p><p id="P4">Using single-cell RNA sequencing (scRNA-seq), here we mapped the transcriptional landscape of iPSC-derived MGE neurons against that of human MGE. Our analysis confirmed the in vitro production of major GABAergic neuronal subclasses with a high-fidelity match to human MGE cell populations, reinforcing the suitability of iPSC-based GABAergic neuron models for studying inhibitory neuron development and NDD pathogenesis. We report that 24S, 25-EC promote neurogenesis via signaling through LXRβ, leading to alterations in the neuronal subtype composition. This study provides novel insights into the regulatory role of 24S, 25-EC on MGE neural progenitors and a potential mechanism by which dysregulated brain oxysterols contribute to the pathogenesis of NDD.</p></sec><sec id="S2" sec-type="results"><title>Results</title><sec id="S3"><title>24S,25-EC promotes LHX6<sup>+</sup> cell production from hiPSCs without affecting ventral patterning</title><p id="P5">Given its prevalence in the fetal brain and its high-affinity binding to smoothened in vitro<sup><xref ref-type="bibr" rid="R19">19</xref></sup>, we first tested the ability of 24S,25-EC to ventralize forebrain neural progenitors. KOLF2 iPSCs were first induced into forebrain neural progenitors without patterning cues<sup><xref ref-type="bibr" rid="R20">20</xref></sup>, followed by exposure to 1mM 24S,25-EC between days 10 and 18 (d10-18, <xref ref-type="supplementary-material" rid="SD2">Figure S1A</xref>). A published MGE induction protocol was used as the positive control<sup><xref ref-type="bibr" rid="R21">21</xref></sup>, where cultures were treated with sonic hedgehog (SHH) and smoothened agonist, purmorphamine (PM), in the same time window. Efficient forebrain neural induction was achieved under all conditions, as demonstrated by the highly enriched presence of FOXG1 at d20 (<xref ref-type="supplementary-material" rid="SD2">Figure S1B-C</xref>). As expected, most cells in SHH-treated positive control cultures expressed the MGE progenitor markers NKX2.1 and OLIG2 (<xref ref-type="supplementary-material" rid="SD2">Figure S1D-E</xref>), and a small population of cells expressed the CGE marker COUTF2 (<xref ref-type="supplementary-material" rid="SD2">Figure S1F</xref>), while few were found in the basal control cultures. However, 24S,25-EC treatment did not lead to an increase in NKX2.1<sup>+</sup> cells over the basal condition, suggesting a lack of smoothened agonist activity.</p><p id="P6">We next investigated whether 24S,25-EC could affect neuronal production from SHH patterned MGE progenitors<sup><xref ref-type="bibr" rid="R22">22</xref>,<xref ref-type="bibr" rid="R21">21</xref></sup>. To this end, 24S,25-EC was added at a later stage between d15-25 of differentiation (<xref ref-type="fig" rid="F1">Figure 1A</xref>). For ease of analysis, this experiment utilized an LHX6-mEmerald reporter human iPSC line that faithfully expresses the genetic knock-in mEmerald in LHX6-expressing neurons<sup><xref ref-type="bibr" rid="R23">23</xref></sup>. LHX6 marks migrating MGE-derived cortical interneurons and some GABAergic projection neurons in vivo. We observed a gradual increase of mEmerald<sup>+</sup> cells from d25 till d50 in both the basal control cultures and those treated with 0.5μM and 1μM 24S,25-EC (<xref ref-type="fig" rid="F1">Figure 1B-C</xref>). However, there were significantly more mEmerald<sup>+</sup> cells in 24S,25-EC treated cultures than in the controls at d25, d30 and d40, although the control cultures caught up by d45. In contrast to the increase in mEmerald<sup>+</sup> cells, protein markers expressed by dividing MGE progenitors, such as NKX2.1, OLIG2 and FOXG1, decreased in cultures exposed to 1μM 24S,25-EC compared to the controls at d25 (<xref ref-type="fig" rid="F1">Figure 1D-E</xref>). We observed no differences in the expression of COUPTF2, a marker of dorsal CGE and LGE.</p><p id="P7">To investigate the cellular mechanism by which 24S,25-EC acts, we exposed d25 cultures to a 2-hour EdU pulse followed by triple immunostaining staining for EdU, Ki67, and NKX2.1 the next day. This experiment allowed for the determination of the cell cycle exit index, which is the ratio of EdU labelled progenitors that have already left the cell cycle (NKX2.1<sup>+</sup>EdU<sup>+</sup>Ki67<sup>-</sup>) to the total number of EdU<sup>+</sup> cells. 24S,25-EC treatment led to an increase in the cell cycle exit index compared to that in the controls (<xref ref-type="fig" rid="F1">Figure 1F-H</xref>). In contrast, we observed a decrease in cycling NKX2.1<sup>+</sup> MGE progenitors in response to 24S 25-EC. Thus, 24S,25-EC promoted the cell cycle exit of MGE neural progenitors.</p></sec><sec id="S4"><title>High MGE specificity and close transcriptomics proximity of iPSC derivatives to human fetal MGE</title><p id="P8">To better characterize the iPSC-derived neurons and the effects of 24S,25-EC, we performed scRNAseq at two developmental stages: d25 and d40, on vehicle control and 24S,25-EC-treated cultures following the previously described treatment length. After quality control and batch effect correction with harmony (<xref ref-type="supplementary-material" rid="SD2">Figure S2A-B</xref>), we obtained 18,579 protein-coding genes out of 114,787 qualifying cells (58,066 control and 56,721 oxysterol-treated). Unsupervised Louvain clustering identified 11 cell clusters with each cell cluster containing different proportions of d25 and d40 samples, respectively (<xref ref-type="fig" rid="F2">Figure 2A-C</xref>, <xref ref-type="supplementary-material" rid="SD2">Figure S2C-D</xref>). For both the control and 24S,25-EC-treated cultures, d25 samples contained more S or G2/M cells than G1 phase cells, as predicted by the CellCycleScoring function in Seurat, while the majority of d40 samples consisted mostly of G1 cells (<xref ref-type="fig" rid="F2">Figure 2D-E</xref>, <xref ref-type="supplementary-material" rid="SD2">Figure S2E-F</xref>), confirming the temporal progression of neuron production as observed by the LHX6 reporter. Consistent with the high proportions of FOXG1<sup>+</sup> and NKX2.1<sup>+</sup> cells on d25 (<xref ref-type="fig" rid="F1">Figure 1D, E</xref>), FOXG1 and NKX2.1 transcripts were detected in all cell clusters, with higher levels concentrated in cycling cells (<xref ref-type="fig" rid="F2">Figure 2D, 2F</xref>). Abundant expression of other known MGE-specific genes was also evident, including NNAT, SOX6, LHX8, MEF2C, CALM1, and the pan-GABAergic marker GAD1 (<xref ref-type="fig" rid="F2">Figure 2F</xref>). NNAT was preferentially detected in S or G2/M cells, while the others were enriched in G1 dominated cell clusters, consistent with MGE neuronal gene markers (<xref ref-type="fig" rid="F2">Figure 2D, 2F</xref>). In contrast, transcripts restricted to or preferentially expressed in the dorsal telencephalon (cortex, DMRTA1, EMX1, PAX6, and TBR1) or LGE (FOXP1, FOXP2, ZNF503, and SALL3) were detected in a few cells and/or at low levels (<xref ref-type="fig" rid="F2">Figure 2F</xref>). Moreover, there was no evident expression of markers indicative of other brain regions, such as the diencephalon (IRX1, EBF3, SOX14, and SLC18A2), midbrain, and hindbrain (FOXA2, PITX3, EN2, and GBX2).</p><p id="P9">We further determined the authenticity of iPSC-derived neurons by mapping our data to a published scRNAseq dataset obtained from human fetal whole ganglionic eminence using FindTransferAnchors followed by the MapQuery function of Seurat<sup><xref ref-type="bibr" rid="R24">24</xref>,<xref ref-type="bibr" rid="R25">25</xref></sup>. This analysis revealed that most iPSC clusters (0, 1, 3-5, 8-10) were mapped to fetal MGE neuron component of the human samples, although a small fraction of cluster 5 (1.27 %) and cluster 9 (0.85%) cells, representing 0.088% of total cells, were predicted as thalamic neurons (<xref ref-type="fig" rid="F2">Figure 2G</xref>). Most cells in clusters 2 and 7 were mapped to human fetal neural progenitors with a small population to the human fetal MGE, whereas cells in cluster 6 were predominantly mapped to the fetal MGE neurons of Shi et al. with a small fraction of the fetal progenitors. Notably, few cells were mapped onto other neural cell types present in the human fetal dataset, such as LGE (0.01% of total cells) and oligodendrocyte progenitor cells (OPC, 0.02% of total cells) and cortical excitatory neurons (0.0008% of total cells) (<xref ref-type="fig" rid="F2">Figure 2G</xref>). These findings indicate that the hESC-derived cell types are transcriptionally aligned closely to the human fetal MGE.</p></sec><sec id="S5"><title>Schizophrenia disease genes are enriched across iPSC-derived MGE neuron populations</title><p id="P10">The analysis described above led to the identification of clusters 7, 2, and 6 as progenitors, late progenitors, and nascent neurons, respectively (<xref ref-type="fig" rid="F3">Figure 3A-B</xref>), whereas clusters 0, 1, 3-5, 8-10 were assigned to neurons based on their preferential expression of neuronal genes (<xref ref-type="fig" rid="F3">Figure 3B</xref>). These neuronal clusters were further annotated using known genesets representing three classes of human fetal MGE neurons previously defined by Mayer et al<sup><xref ref-type="bibr" rid="R26">26</xref></sup> (<xref ref-type="supplementary-material" rid="SD2">Figure S2G</xref>, <xref ref-type="fig" rid="F3">Figure 3C</xref>). Cluster 1 was designated as B1 SST-CCK cortical interneurons, as they showed high levels of similarity to branch 1 human fetal MGE cells exhibiting transcriptional characteristics of cortical interneurons expressing PLS3, DLX2, ARX, EPHA5, NXPH1, DCLK2, and SST (<xref ref-type="fig" rid="F3">Figure 3C</xref>, <xref ref-type="supplementary-material" rid="SD1">Table S1</xref>). Clusters 4, 5, and 9 feature branch 2 GABAergic projection neurons that show enriched expression of RALYL, PCDH7, NRP1, ZFHX3, LRP1B, RELN, and TLE4 compared to other neuronal clusters. Cluster 4 (brach 2 group 1) neurons also show differential expression of EBF1 (<xref ref-type="fig" rid="F3">Figure 3C</xref>). Clusters 0, 3, and 8 showed high transcriptomic alignment to branch 3 neurons, which were enriched with SHISA9, CNTANP2, ADARB2, ENC1, and LHX8 in comparison to branch 1 and branch 2 neurons. Descendants of this branch account for most cholinergic projection neurons, cholinergic striatal interneurons, and GABAergic globus pallidus projection neurons34,35. We found that Cluster 10 cells shared the expression of all the branch-specific genes mentioned above as well as higher levels of NKX2.1 and SFTA3 compared to other neuronal clusters; therefore, we designated these cells as unspecified neurons (<xref ref-type="fig" rid="F3">Figure 3C</xref>).</p><p id="P11">Schizophrenia risk alleles have been shown to be over-represented in human MGE-derived neurons<sup><xref ref-type="bibr" rid="R7">7</xref>, <xref ref-type="bibr" rid="R9">9</xref>–<xref ref-type="bibr" rid="R11">11</xref></sup>. To further assess the relevance of our iPSC-MGE cells for disease modelling, we conducted gene set enrichment analysis using the latest publicly available GWAS dataset for schizophrenia<sup><xref ref-type="bibr" rid="R27">27</xref></sup>. The expressed genes of all neuron groups were enriched in schizophrenia (FDR padj &lt; 0.05, <xref ref-type="fig" rid="F3">Figure 3D</xref>). To ascertain that the enrichment was specific to each cell type and not due to the genes shared by these neurons, we used the Expression Weighted Celltype Enrichment (EWCE, see <xref ref-type="sec" rid="S9">method</xref>) package to calculate gene expression specificity for each group<sup><xref ref-type="bibr" rid="R7">7</xref></sup>. Testing only the top 10% of specific genes revealed that, with the exception of B3 projection interneuron 2, all neuronal types were still enriched for schizophrenia-associated genes (<xref ref-type="fig" rid="F3">Figure 3D</xref>). Consistent with findings in the human brain, neural progenitor cells were not associated with the disease. These findings provide further support for the iPSC-MGE neurons as a suitable experimental platform for modelling neuropsychiatric and neurodevelopmental disorders.</p></sec><sec id="S6"><title>24S,25-EC exhibits differential effect on neuronal subclasses</title><p id="P12">To gain insight into the effects of 24S, 25-EC on different cell populations, we compared the proportion of each cell cluster between the control and oxysterol-treated conditions. Using the whole dataset containing both d25 and d40 cells, we observed a significant reduction in cells of 24S, 25-EC treated progenitor cluster (-0.58&gt;Log2 fold change&gt;0.58, FDR&lt;0.05, <xref ref-type="fig" rid="F4">Figure 4A</xref>), providing independent support for 24S, 25-EC-induced cell cycle exit as measured by EdU labelling (<xref ref-type="fig" rid="F1">Figure 1F-H</xref>). Intriguingly, we detected a significant reduction in unspecified neurons and an increase in two branch 3 neuronal clusters (B3-projection/interneurons 1 and 2, <xref ref-type="fig" rid="F4">Figure 4A</xref>). By performing the comparison by date separately, we found that the reduction in unspecified neurons was already present at d25, whereas an increase in branch 3 neurons occurred later at d40 (<xref ref-type="supplementary-material" rid="SD2">Figure S2H</xref>). We also observed a reduction in the number of B1-cortical interneurons and an increase in the number of nascent neurons at d40. No significant changes in B2 neuronal clusters were detected by any means of comparison, suggesting a preferential effect of 24S, 25-EC on Branches 1 and 3 neuronal clusters.</p><p id="P13">To explore the potential mechanisms by which 24S, 25-EC alter cellular composition, we analyzed differential gene expression between oxysterol-treated and control samples within each cell cluster considering the direction of changes at d25 and d40 in tandem. Most genes were up- or downregulated in EC-treated samples at only one time point (adjusted p value&lt;0.05, log2 fold change ≥ 0.25). These differentially expressed genes (DEGs) were referred to as d25-High/d25-Low and d40-High/d40-Low, respectively (<xref ref-type="supplementary-material" rid="SD1">Table S2</xref>). A small proportion of DEGs showed the same or opposite direction of changes at d25 and d40. These DEGs are referred to as Continuous High/Low and d25-High (or low) reverse, respectively (<xref ref-type="fig" rid="F4">Figure 4B</xref> and <xref ref-type="supplementary-material" rid="SD1">Table S2</xref>). Considering that oxysterol treatment ends at d25, we hypothesized that the d25 DEGs are likely to be enriched with direct targets and downstream pathways of oxysterol signaling, whereas the d40 DEGs may reflect secondary or long-term changes in the associated cell populations.</p><p id="P14">At d25, the progenitor and late progenitor populations responded to 24S, 25-EC with a greater number of DEGs compared to most of the neuronal clusters, as both ‘High’ and ‘Low’ (<xref ref-type="fig" rid="F4">Figure 4B</xref>). B3 projection/interneuron 3 and B1 SST-CCK cortical interneurons also showed many d25 DEGs (<xref ref-type="fig" rid="F4">Figure 4B</xref>). In contrast, d40 DEGs were mostly found in the nascent neurons, late progenitors, and neuronal populations (<xref ref-type="fig" rid="F4">Figure 4B</xref>). These observations support the notion that 24S, 25-EC primarily acts on progenitor cells and disproportionately affects B1 SST-CCK cortical interneurons and B3 projections/interneurons among neuronal types.</p><p id="P15">However, d25-High DEGs showed contrasting GO enrichment profiles in progenitors and neurons. The progenitor and late progenitor d25-High DEGs were mainly related to the cell cycle, transcription regulation, and TGF- and WNT signalling (<xref ref-type="fig" rid="F4">Figure 4C</xref>), whereas those in neurons were mainly involved in neuronal maturation and function, such as axonogenesis, synaptic assembly, and cellular transport (<xref ref-type="supplementary-material" rid="SD1">Table S3</xref>).</p><p id="P16">Interestingly, d25-High DEGs of progenitors, nascent neurons, B3 projection/interneurons 3 and B1 SST-CCK cortical interneurons were significantly over-represented with LXRß target genes (<xref ref-type="fig" rid="F4">Figure 4D</xref>, <xref ref-type="supplementary-material" rid="SD1">Table S3</xref>) although B2 GABAergic neuron 2 was also enriched with targets of LXRα (<xref ref-type="supplementary-material" rid="SD2">Figure S3A</xref>) (<ext-link ext-link-type="uri" xlink:href="https://tflink.net/">https://tflink.net/</ext-link>)<sup><xref ref-type="bibr" rid="R28">28</xref></sup>, suggesting a role for LXRß in mediating oxysterol function and is consistent with LXRß being the dominant LXR isoform expressed in the brain<sup><xref ref-type="bibr" rid="R29">29</xref></sup>. Moreover, as another support to EC-induced increase of neural progenitor cell cycle exit (<xref ref-type="fig" rid="F1">Figure 1H</xref>), the LXRß targets identified in progenitor d25-High DEGs were mainly associated with cell cycle, transcription and regulation (<xref ref-type="supplementary-material" rid="SD2">Figure S3B</xref>).</p><p id="P17">Next, we performed SCENIC analysis to infer the regulatory networks underlying the actions of oxysterol. D25-High transcription factors were found to have the highest betweenness centrality measures within the cell type-specific transcriptomic networks (<xref ref-type="supplementary-material" rid="SD2">Figure S3C</xref>), implicating them as the likely ‘hub’ genes central to oxysterol-dependent regulatory mechanisms in the responding progenitor cells. Crucially, many of these transcription factors, such as E2F3, HES1, TCF3/12, SMAD3, REST and YY1, are known regulators of cell cycle and neurogenesis as well as being direct targets of LXRβ (E2F3, HES1, TCF3/12, SMAD3) or its co-receptor RXR (REST, YY1)<sup><xref ref-type="bibr" rid="R28">28</xref>, <xref ref-type="bibr" rid="R30">30</xref>–<xref ref-type="bibr" rid="R36">36</xref></sup>.</p></sec><sec id="S7"><title>24S,25-EC promotes MGE progenitor neurogenesis via LXR</title><p id="P18">Our scRNAseq analysis highlights LXR as the likely signaling receptor acting in MGE progenitors that mediates the 24S,25-EC-regulation of GABAergic neurogenesis. To provide experimental support, we pharmacologically activated LXR using the selective LXR agonist, GW3965. When applied to iPSC-MGE progenitors during d15-d25, GW3965 mimicked the effects of 24S,25-EC, as demonstrated by an increase in the number of LHX6-mEmerald<sup>+</sup> neurons (<xref ref-type="fig" rid="F5">Figure 5A-D</xref>). Moreover, the EdU incorporation assay showed that, similar to 24S,25-EC, GW3965 treatment resulted in a reduction in cycling NKX2.1<sup>+</sup> MGE progenitors (NKX2.1<sup>+</sup>Ki67<sup>+</sup>) and an increase in cell cycle exit index (<xref ref-type="fig" rid="F5">Figure 5E</xref>). In contrast, the addition of the LXR antagonist GSK2033 abolished the neurogenic promoting effect of 24S,25-EC by blocking cell cycle exit (<xref ref-type="supplementary-material" rid="SD2">Figure S4</xref>).</p><p id="P19">LXRβ is the predominant LXR receptor in the brain<sup><xref ref-type="bibr" rid="R29">29</xref></sup>. To exclude potential non-specific effects of the LXR agonist/antagonist, we re-examined 24S,25-EC on neural progenitor behavior using a CRISPR-engineered hESC line deficient in LXRβ and its isogenic wild-type control line<sup><xref ref-type="bibr" rid="R18">18</xref></sup>. Using the same experimental design as shown in <xref ref-type="fig" rid="F1">figure 1A</xref>, we found that while 24S,25-EC treatment resulted in a decrease in S phase (NKX2.1<sup>+</sup>EdU<sup>+</sup>) and cycling (NKX2.1<sup>+</sup>Ki67<sup>+</sup>) MGE progenitors in the isogenic wild-type control culture, the same treatment had no effect on LXRβ-knockout MGE progenitors (<xref ref-type="fig" rid="F5">Figure 5F-I</xref>). Together, our pharmacological and genetic approaches demonstrate that 24S,25-EC promotes neural progenitor cell cycle exit via LXRβ receptor.</p></sec></sec><sec id="S8" sec-type="discussion"><title>Discussion</title><p id="P20">The present study identified a new role for oxysterol-LXR signaling in cortical GABAergic neurogenesis and provided insights into a potential mechanism by which distorted oxysterol metabolism affects GABAergic neuron subtype composition that may underlie the pathogenesis of neurodevelopmental disorders.</p><p id="P21">Oxysterols are by-products of cholesterol biosynthesis and metabolism, and are capable of interacting with signaling pathways that play pivotal roles in neural development<sup><xref ref-type="bibr" rid="R19">19</xref>,<xref ref-type="bibr" rid="R37">37</xref></sup>. Altered levels of brain-derived oxysterol in the plasma or cerebrospinal fluid have been reported in individuals with neurodegenerative diseases<sup><xref ref-type="bibr" rid="R38">38</xref>–<xref ref-type="bibr" rid="R41">41</xref></sup> and neurodevelopmental disorders<sup><xref ref-type="bibr" rid="R38">38</xref>–<xref ref-type="bibr" rid="R44">44</xref></sup>, while 24S, 25-EC was found to be produced at abnormally high levels in iPSC-derived cortical cells from autism patients and those carrying an autism risk gene mutation<sup><xref ref-type="bibr" rid="R18">18</xref></sup>. However, the roles of dysregulated oxysterols in disease pathogenesis remain largely unknown.</p><p id="P22">GABAergic neurons comprise an extremely heterogeneous group of cells with many specialized subtypes. Distinct neuronal subtypes populate the different layers of the adult cortex, striatum, and hypothalamus<sup><xref ref-type="bibr" rid="R45">45</xref></sup>. Single-cell transcriptomic studies have indicated that distinguishable GABAergic neuron subtypes emerge during fetal development, at a time when precursors migrate, morphologically mature, and establish synaptic connections to other cortical neurons<sup><xref ref-type="bibr" rid="R24">24</xref>,<xref ref-type="bibr" rid="R26">26</xref>,<xref ref-type="bibr" rid="R46">46</xref></sup>. Hence, changes in cortical cues will impact GABAergic neuron fates and consequently their functions.</p><p id="P23">In this study, the majority (&gt;75%) of neurons in all neuronal clusters were born after d25, when 24S, 25-EC treatment ended. However, only three neuron populations (B3 projection/interneurons 1 and 2 and unspecified neurons) were affected, suggesting a selective effect of 24S, 25-EC either on pre-committed subtype neural progenitors or a bias on differentiation of common progenitors towards specific fates. Our regulatory network analysis of the affected neuronal populations did not reveal potential transcription factor programs that preferentially drive or inhibit the production of these neuron types but common pro-neurogenesis regulators (see below). Moreover, compared to other neuronal types, a greater proportion of B3 projection/interneurons 1 and 2 were generated after d25. Hence, there is increased chance of 24S, 25-EC effect on ‘late born’ neurons.</p><p id="P24">During development, the birthdates of MGE-derived neuronal subtypes are temporally regulated, which is a critical factor in determining the interneuron subtype diversity<sup><xref ref-type="bibr" rid="R47">47</xref>–<xref ref-type="bibr" rid="R49">49</xref></sup>. While the link between birthdates of MGE-derived neurons and interneuron subtypes has been established, the instructive mechanism that delineates how interneuron diversity is shaped in relation to the moment they exit the cell cycle is poorly understood, nor how extracellular cues might regulate this process and therefore potentially affect interneuron diversity. This study provides proof of principle that environmental changes in the developing cortex, such as altered levels of 24S, 25-EC production by cortical cells, may alter the subtype trajectory of GABAergic neurons and subsequently alter the global profile of the inhibitory-excitatory circuitry implicated in neurodevelopmental disorders.</p><p id="P25">HES1, SMAD3, and TCF3/12 were among the top regulated transcription factors identified by regulatory network analysis as likely ‘hub’ transcription factors mediating 24S, 25-EC regulation of neurogenesis (<xref ref-type="supplementary-material" rid="SD2">Figure S3C</xref>). As further support to this notion, all these transcription factors are direct targets of LXRβ (<ext-link ext-link-type="uri" xlink:href="https://tflink.net">https://tflink.net</ext-link>), the presence of which is required for 24S, 25-EC-dependent neurogenesis. Interestingly, TGFβ has been shown to accelerate the generation of LHX6<sup>+</sup> MGE-like neurons by promoting neural progenitor cell cycle exit<sup><xref ref-type="bibr" rid="R23">23</xref></sup>, while the interaction between the WNT and NOTCH pathways has been shown to play a role in regulating human MGE progenitors<sup><xref ref-type="bibr" rid="R50">50</xref></sup>. It is worthy of mention that WNT activation can either promote neural progenitor proliferation or differentiation depending on the context<sup><xref ref-type="bibr" rid="R51">51</xref>–<xref ref-type="bibr" rid="R56">56</xref></sup>. One such context is the presence of other signaling molecules and the crosstalk between them. Therefore, future studies are needed to experimentally delineate how LXR interacts with WNT and/or TGFβ signaling.</p><p id="P26">Importantly, our scRNAseq analysis provides unbiased evidence of the high level of transcriptomic proximity of iPSC-derived GABAergic neurons to human MGE-derived neurons in vivo, making these cells a robust platform for modelling neurodevelopmental and psychiatric disorders. Moreover, rodent MGE or iPSC-derived MGE-like neurons grafted into numerous brain regions have demonstrated their capacity to inhibit local circuitry<sup><xref ref-type="bibr" rid="R57">57</xref>–<xref ref-type="bibr" rid="R60">60</xref></sup>, encouraging the pursuit of this approach for emerging therapeutic applications. Our study indicates that directing stem cell differentiation towards a desired GABAergic subtype is possible by manipulating extrinsic signaling, hence providing grounds to tailor neuronal diversity for enhanced therapeutic outcomes.</p></sec><sec id="S9" sec-type="materials | methods"><title>Materials and Methods</title><sec id="S10"><title>HESC culture and neuronal differentiation</title><p id="P27">The hESC lines used in this study were corrected KOLF2 (KOLF2.1J) hiPSC line<sup><xref ref-type="bibr" rid="R61">61</xref></sup>, KOLF2-derived LHX6-emerald interneuron reporter line<sup><xref ref-type="bibr" rid="R23">23</xref></sup>, iCas9 and iCas9-derived LXRβ knockout line<sup><xref ref-type="bibr" rid="R18">18</xref></sup>. All hPSCs were cultured on Cultrex (R&amp;D systems) coated plastics in E8 Flex media (ThermoFisher) in a humidified 37°C incubator with 5% CO<sub>2</sub>. Media was changed daily and cells passaged mechanically with 0.02% EDTA at 80% confluence. MGE differentiation followed procedures described previously<sup><xref ref-type="bibr" rid="R23">23</xref></sup>. Briefly, cells from two 80% confluent wells of a 6-well plate were plated onto a 12-well plate previously coated with Cultrex (R&amp;D systems) in E8 media (Day 0) and changed to N2B27 the next day. Cells were induced to neuroectoderm fate by LDN-193189 (100nM, Tocris), SB-431542 (10µM, Tocris) and XAV-939 (2µM, Stratech) from day 1-10 followed by ventralisation with a combination of recombinant Sonic Hedgehog (SHH, 200 ng/ml, Peprotech) and a small molecule SHH agonist purmorphamine (PM, 1µM, Merck) from day 11-18. To promote terminal differentiation and cell survival, cultures were treated with BDNF (10ng/ml, Peprotech) from day 25 until harvest. For oxysterol experiments, 24S, 25-epoxycholesterol (0.5-1 μM, Abcam) was added to N2B27 media from day 15 to 25. For testing MGE induction effect of 24S, 25-EC (d10-18 treatment), neural differentiation follows the same procedure without SHH and PM. For pharmacological interrogation of LXR singaling, ethanol control or small molecule LXR agonist GW3965 (0.5, 1 µM, Stratech) and/or antagonist GSK2033 (0.5, 1 µM, stratech) were added during d15-25.</p></sec><sec id="S11"><title>Immunocytochemistry</title><p id="P28">Cultured cells were fixed in 3.7% PFA for 15 min at 4 ºC. For nuclear antigen detection, an additional fixation with methanol gradient was performed, which includes 5 mins each in 33% and 66% methanol at room temperature followed by 100% methanol for 20 min at -20 ºC. Cells were returned to PBS containing 0.3% Triton-X-100 (PBS-T) via inverse gradient. Cells were then permeabilized with three 10-minute washes in PBS-T and then blocked in PBS-T containing 3% BSA and 5% donkey serum. Cells were incubated with primary antibodies in blocking solution overnight at 4°C. Following three PBS-T washes, Alexa-Fluor secondary antibodies were added at 1:1000 in PBS-T for 1 hour at ambient temperature in the dark. Three PBS washes were then performed that included once with DAPI at 1:3000. Images were taken on a PerkinElmer OperaPhenix or a Leica DMI6000B inverted microscope. Quantification was carried out in Cell Profiler (cellprofiler.org) or manually using ImageJ (imagej.net) by examining 2-10 randomly selected fields of views from each of the 3 technical replicates performed in at least 3 independent differentiations (biological replicates). Each counting field is presented as a dot in relevant bargraphs with the number of counting fields for each bargraph shown in <xref ref-type="supplementary-material" rid="SD1">table S4</xref>. The following antibodies were used for the immunofluorescence studies: rabbit anti-FOXG1 (Abcam AB18259, 1:250), NKX2.1 (Abcam AB76013, 1:1000), OLIG2 (R&amp;D systems AF2418, 1:200), COUPTF2 (R&amp;D systems PP-H7147-00, 1:100), anti-Ki67 (ACK02, 1:1000), secondary antibodies (Alexa Fluor 488, 594 and 647, 1:1000)</p></sec><sec id="S12"><title>EdU Labelling and detection</title><p id="P29">EdU labelling and detection was performed using a Click-iT EdU Assay kit (Thermo Fisher). Cells were incubated with EdU for 2 hours at specified day of differentiation, followed by fixation in 3.7% PFA for 15 min at 4 ºC. EdU detection was carried out as per manufacturer’s protocol before antibody staining. Cell cycle exit index of NKX2.1<sup>+</sup> MGE progenitors was calculated as the ratio of NKX2.1<sup>+</sup>EdU<sup>+</sup>Ki67<sup>−</sup> cells to the total EdU<sup>+</sup> population. Image capture and quantification was performed as described in ‘Immunocytochemistry’</p></sec><sec id="S13"><title>Single cell RNA sequencing and data processing</title><p id="P30">For scRNA-seq, differentiating MGE cells were collected and dissociated into single cells at d25 and d40. Briefly, cells were treated with Accutase (ThermoFisher) for 5–7 minutes at 37°C. The suspension was centrifuged at 200g, 4°C for 5 minutes to remove supernatant. Cells were then re-suspended in cold PBS with 0.5% BSA and passed through a 40μm Flowmi cell strainer. Three biological replicates of the same stage were pooled together. For quality control, cell viability was assessed by trypan blue staining and confirmed to be above 80%. Cells were loaded onto the 10X Chromium Single Cell Platform and libraries were constructed using the Single Cell 3’ Library v3.1 kit (10X Genomics) as per manufacturer’s protocol. The libraries were sequenced on the Illumina Novaseq 6000 instrument using Novaseq S2 100 cycle kit aiming for a depth of approximately 150,000 reads/cell. Sequencing was run as paired-end, 100 cycles in a standard workflow.</p><p id="P31">Raw reads were processed using Cell Ranger 7.1.0 (10x Genomics) and aligned to <italic>Homo sapiens</italic> GRCh38-2020-A. All downstream analysis was performed using the R package Seurat (v 5.2)<sup><xref ref-type="bibr" rid="R62">62</xref></sup>. For quality control, a Median Absolute Deviation (MAD) method was applied using the isOutlier function from the scuttle package (1.8.4)<sup><xref ref-type="bibr" rid="R63">63</xref></sup>. Cells with nFeature 2 MADs lower than the median, median nCouns above or lower than 2 MADs, and the fraction of mitochondrial genes above 2 MADs were discarded. The normalisation and variance stabilisation of molecular count data were performed using the sctransform function in Seurat<sup><xref ref-type="bibr" rid="R64">64</xref></sup>. This function was used to also remove confounding sources of variation such as mitochondrial mapping percentage. The batch effect was removed using harmony (v1.1.0)<sup><xref ref-type="bibr" rid="R65">65</xref></sup>. Uniform manifold approximation and projection (UMAP) and unsupervised Louvain clustering were performed using RunUMAP, FindNeighbors and FindClusters function based on the first 30 principal components. Cell cycle phase scores were calculated using the CellCycleScoring function based on the expression of canonical G2/M and S phase markers<sup><xref ref-type="bibr" rid="R66">66</xref></sup>. For annotation, cluster-specific gene markers were found with FindConservedMarkers function with min.pct=0.25, logfc.threshold=0.25, statistically significant markers p.adjust&lt;0.05 were tested (hypergeometric test) for gene enrichment in specific makers of MGE branches previously reported in Mayer, et al. 2018<sup><xref ref-type="bibr" rid="R26">26</xref></sup>.</p><p id="P32">To compare the transcriptome similarity with published human GE scRNAseq data<sup><xref ref-type="bibr" rid="R24">24</xref></sup>, we performed anchor-based label transfer implemented in Seurat. The anchors between the query and reference datasets were identified and filtered using the FindTransferAnchors() function with the top 50 dimensions. Then, the MapQuery() wrapper function was used to project our data onto human brain data to visualise cell type similarities between datasets. Differential gene expression analyses were performed using the FindAllMarkers and FindMarkers function with Wilcoxon signed-rank test and Bonferroni correction for total number of genes included in the analysis. Proportion change analysis was performed using the scProportionTest 0.0.0.9 package<sup><xref ref-type="bibr" rid="R67">67</xref></sup> with 10000 permutations followed by FDR correction. Gene ontology (GO) enrichment was performed using the enrichGO function in the clusterProfiler 4.12.6 package<sup><xref ref-type="bibr" rid="R68">68</xref></sup> based on <italic>Homo sapiens</italic> GO term database retrieved by the org.Hs.eg.db 3.19.1 package. Gene set over-representation tests were performed using the enricher function in the clusterProfiler package. LXRα and LXRß targets were obtained from TFLink gateway (<ext-link ext-link-type="uri" xlink:href="https://tflink.net">https://tflink.net</ext-link>), including only TF-target interactions from Chromatin immunoprecipitation and/or electrophoretic mobility shift assay experiments. SCENIC analysis was performed using pySCENIC 0.12.1<sup><xref ref-type="bibr" rid="R69">69</xref>,<xref ref-type="bibr" rid="R70">70</xref></sup>. cisTarget databases used for SCENIC analysis were the Homo sapiens - hg38 – refseq_r80_v10- SCENIC+ databases downloaded from <ext-link ext-link-type="uri" xlink:href="https://resources.aertslab.org/cistarget/">https://resources.aertslab.org/cistarget/</ext-link>. SCENIC regulon enrichment score (AUC) was used for differential testing using the Wilcoxon signed-rank test with Bonferroni correction for the total number of regulons detected. Gene networks were visualised and analysed with Analyze Network in Cytoscape 3.10.2<sup><xref ref-type="bibr" rid="R71">71</xref></sup></p></sec><sec id="S14"><title>Gene enrichment analysis</title><p id="P33">Public summary statistics associated to the latest schizophrenia GWAS<sup><xref ref-type="bibr" rid="R27">27</xref></sup> were downloaded from <ext-link ext-link-type="uri" xlink:href="https://www.med.unc.edu/pgc/download-results/scz/">https://www.med.unc.edu/pgc/download-results/scz/</ext-link>. Summary statistics were QC and cleaned using R package MungeSumstats<sup><xref ref-type="bibr" rid="R72">72</xref></sup>. SNPs were mapped to genes with annotation windows of 35 kb and 10 kb upstream and downstream, respectively. Dupplicated rsIDs for the same SNP were excluded from analysis. The Seurat object containing the expression dataset was converted into a CellTypeDataset object using the EWCE R package, as reported by Skene et al<sup><xref ref-type="bibr" rid="R7">7</xref></sup>. Main cell type association analysis was carried out using the MAGMA.Celltyping running MAGMA v1.10<sup><xref ref-type="bibr" rid="R7">7</xref>,<xref ref-type="bibr" rid="R73">73</xref></sup> using a combination of linear and the top 10% most specific genes for each cell type.</p></sec><sec id="S15"><title>Statistical analysis</title><p id="P34">RNA sequencing data were analyzed separately as described above. The SPSS Statistics 27 software (IBM) was used for all other statistical analyses. All quantified data were plotted in Prism 10 (GraphPad Software) and are reported as the mean ± SEM from at least three independent experiments, unless otherwise specified. Data were tested for normality using the Shapiro-Wilk test and for equal variance with Levene’s test before performing statistical analyses by one-way ANOVA or two-way ANOVA (depending on the number of dependent variables) with post-hoc Bonferroni for equal variances or Dunnett’s T3 test for multiple comparisons where equal variances criteria were not met. The Kruskal-Wallis test with post-hoc Dunn’s test for pairwise comparison was used when the parametric test was not suitable. The results were considered statistically significant at p&lt;0.05.</p></sec></sec><sec sec-type="supplementary-material" id="SM"><title>Supplementary Material</title><supplementary-material content-type="local-data" id="SD1"><label>Supplemental tables</label><media xlink:href="EMS207079-supplement-Supplemental_tables.xlsx" mimetype="application" mime-subtype="vnd.openxmlformats-officedocument.spreadsheetml.sheet" id="d125aAcEbB" position="anchor"/></supplementary-material><supplementary-material content-type="local-data" id="SD2"><label>Supplementary Material</label><media xlink:href="EMS207079-supplement-Supplementary_Material.pdf" mimetype="application" mime-subtype="pdf" id="d125aAcEcB" position="anchor"/></supplementary-material></sec></body><back><ack id="S16"><title>Acknowledgements</title><p>We thank Dr. Francesco Bedogni, Prof. Kathryn Peall and members of the M.L. laboratory for helpful discussions during this study. RNA sequencing analysis was performed using the computational facilities of the Advanced Research Computing@Cardiff (ARCCA) Division, Cardiff University. This research was funded by the U.K. Medical Research Council (grant number MR/L020807) and EU Horizon 2020 Program ‘NSC-reconstruct’ (grant number No. 874758) to M.L.</p></ack><fn-group><fn id="FN1" fn-type="con"><p id="P35"><bold>Author Contribution</bold></p><p id="P36">M.C-S. M.L. conceived of the study and designed the experiments. M. C-S. and E.K. carried out and analyzed the hESC and hiPSC experiments. M.C-S. S.D. and N.N.V captured the scRNA-seq experiment samples, while S. D. made the libraries. M.C-S. Z. L. and E.K. performed data analysis. D.C.F. performed gene enrichment analysis. M.F. provided guidance on scRNA-seq data analysis to M.C-S and E.K. M.L. wrote the paper. All authors edited and approved the manuscript.</p></fn><fn id="FN2" fn-type="conflict"><p id="P37"><bold>Declaration of interests</bold></p><p id="P38">The authors declare no competing financial interests.</p></fn><fn id="FN3"><p id="P39"><bold>Inclusion and diversity</bold></p><p id="P40">We support inclusive, diverse, and equitable conduct of research.</p></fn></fn-group><ref-list><ref id="R1"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Marín</surname><given-names>O</given-names></name></person-group><article-title>Interneuron dysfunction in psychiatric disorders</article-title><source>Nat Rev Neurosci</source><year>2012</year><volume>13</volume><fpage>107</fpage><lpage>120</lpage><pub-id pub-id-type="pmid">22251963</pub-id></element-citation></ref><ref id="R2"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Le Magueresse</surname><given-names>C</given-names></name><name><surname>Monyer</surname><given-names>H</given-names></name></person-group><article-title>GABAergic interneurons shape the functional maturation of the cortex</article-title><source>Neuron</source><year>2013</year><volume>77</volume><fpage>388</fpage><lpage>405</lpage><pub-id pub-id-type="pmid">23395369</pub-id></element-citation></ref><ref id="R3"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lunden</surname><given-names>JW</given-names></name><name><surname>Durens</surname><given-names>M</given-names></name><name><surname>Phillips</surname><given-names>AW</given-names></name><name><surname>Nestor</surname><given-names>MW</given-names></name></person-group><article-title>Cortical interneuron function in autism spectrum condition</article-title><source>Pediatr Res</source><year>2019</year><volume>85</volume><fpage>146</fpage><lpage>154</lpage><pub-id pub-id-type="pmid">30367159</pub-id></element-citation></ref><ref id="R4"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rapanelli</surname><given-names>M</given-names></name><name><surname>Frick</surname><given-names>LR</given-names></name><name><surname>Pittenger</surname><given-names>C</given-names></name></person-group><article-title>The role of interneurons in autism and tourette syndrome</article-title><source>Trends Neurosci</source><year>2017</year><volume>40</volume><fpage>397</fpage><lpage>407</lpage><pub-id pub-id-type="doi">10.1016/j.tins.2017.05.004</pub-id><pub-id pub-id-type="pmcid">PMC5528854</pub-id><pub-id pub-id-type="pmid">28578790</pub-id></element-citation></ref><ref id="R5"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Filice</surname><given-names>F</given-names></name><name><surname>Janickova</surname><given-names>L</given-names></name><name><surname>Henzi</surname><given-names>T</given-names></name><name><surname>Bilella</surname><given-names>A</given-names></name><name><surname>Schwaller</surname><given-names>B</given-names></name></person-group><article-title>The parvalbumin hypothesis of autism spectrum disorder</article-title><source>Front Cell Neurosci</source><year>2020</year><volume>14</volume><elocation-id>577525</elocation-id><pub-id pub-id-type="doi">10.3389/fncel.2020.577525</pub-id><pub-id pub-id-type="pmcid">PMC7775315</pub-id><pub-id pub-id-type="pmid">33390904</pub-id></element-citation></ref><ref id="R6"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Verret</surname><given-names>L</given-names></name><name><surname>Mann</surname><given-names>EO</given-names></name><name><surname>Hang</surname><given-names>GB</given-names></name><name><surname>Barth</surname><given-names>AMI</given-names></name><name><surname>Cobos</surname><given-names>I</given-names></name><name><surname>Ho</surname><given-names>K</given-names></name><name><surname>Devidze</surname><given-names>N</given-names></name><name><surname>Masliah</surname><given-names>E</given-names></name><name><surname>Kreitzer</surname><given-names>AC</given-names></name><name><surname>Mody</surname><given-names>I</given-names></name><etal/></person-group><article-title>Inhibitory interneuron deficit links altered network activity and cognitive dysfunction in Alzheimer model</article-title><source>Cell</source><year>2012</year><volume>149</volume><fpage>708</fpage><lpage>721</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2012.02.046</pub-id><pub-id pub-id-type="pmcid">PMC3375906</pub-id><pub-id pub-id-type="pmid">22541439</pub-id></element-citation></ref><ref id="R7"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Skene</surname><given-names>NG</given-names></name><name><surname>Bryois</surname><given-names>J</given-names></name><name><surname>Bakken</surname><given-names>TE</given-names></name><name><surname>Breen</surname><given-names>G</given-names></name><name><surname>Crowley</surname><given-names>JJ</given-names></name><name><surname>Gaspar</surname><given-names>HA</given-names></name><name><surname>Giusti-Rodriguez</surname><given-names>P</given-names></name><name><surname>Hodge</surname><given-names>RD</given-names></name><name><surname>Miller</surname><given-names>JA</given-names></name><name><surname>Muñoz-Manchado</surname><given-names>AB</given-names></name><etal/></person-group><article-title>Genetic identification of brain cell types underlying schizophrenia</article-title><source>Nat Genet</source><year>2018</year><volume>50</volume><fpage>825</fpage><lpage>833</lpage><pub-id pub-id-type="doi">10.1038/s41588-018-0129-5</pub-id><pub-id pub-id-type="pmcid">PMC6477180</pub-id><pub-id pub-id-type="pmid">29785013</pub-id></element-citation></ref><ref id="R8"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rummel</surname><given-names>CK</given-names></name><name><surname>Gagliardi</surname><given-names>M</given-names></name><name><surname>Ahmad</surname><given-names>R</given-names></name><name><surname>Herholt</surname><given-names>A</given-names></name><name><surname>Jimenez-Barron</surname><given-names>L</given-names></name><name><surname>Murek</surname><given-names>V</given-names></name><name><surname>Weigert</surname><given-names>L</given-names></name><name><surname>Hausruckinger</surname><given-names>A</given-names></name><name><surname>Maidl</surname><given-names>S</given-names></name><name><surname>Hauger</surname><given-names>B</given-names></name><etal/></person-group><article-title>Massively parallel functional dissection of schizophrenia-associated noncoding genetic variants</article-title><source>Cell</source><year>2023</year><volume>186</volume><fpage>5165</fpage><lpage>5182</lpage><elocation-id>e33</elocation-id><pub-id pub-id-type="pmid">37852259</pub-id></element-citation></ref><ref id="R9"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Anderson</surname><given-names>KM</given-names></name><name><surname>Collins</surname><given-names>MA</given-names></name><name><surname>Chin</surname><given-names>R</given-names></name><name><surname>Ge</surname><given-names>T</given-names></name><name><surname>Rosenberg</surname><given-names>MD</given-names></name><name><surname>Holmes</surname><given-names>AJ</given-names></name></person-group><article-title>Transcriptional and imaging-genetic association of cortical interneurons, brain function, and schizophrenia risk</article-title><source>Nat Commun</source><year>2020</year><volume>11</volume><elocation-id>2889</elocation-id><pub-id pub-id-type="doi">10.1038/s41467-020-16710-x</pub-id><pub-id pub-id-type="pmcid">PMC7280213</pub-id><pub-id pub-id-type="pmid">32514083</pub-id></element-citation></ref><ref id="R10"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cameron</surname><given-names>D</given-names></name><name><surname>Vinh</surname><given-names>N-N</given-names></name><name><surname>Prapaiwongs</surname><given-names>P</given-names></name><name><surname>Perry</surname><given-names>EA</given-names></name><name><surname>Walters</surname><given-names>JTR</given-names></name><name><surname>Li</surname><given-names>M</given-names></name><name><surname>O’Donovan</surname><given-names>MC</given-names></name><name><surname>Bray</surname><given-names>NJ</given-names></name></person-group><article-title>Genetic implication of prenatal gabaergic and cholinergic neuron development in susceptibility to schizophrenia</article-title><source>Schizophr Bull</source><year>2024</year><volume>50</volume><fpage>1171</fpage><lpage>1184</lpage><pub-id pub-id-type="doi">10.1093/schbul/sbae083</pub-id><pub-id pub-id-type="pmcid">PMC11349020</pub-id><pub-id pub-id-type="pmid">38869145</pub-id></element-citation></ref><ref id="R11"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cameron</surname><given-names>D</given-names></name><name><surname>Mi</surname><given-names>D</given-names></name><name><surname>Vinh</surname><given-names>N-N</given-names></name><name><surname>Webber</surname><given-names>C</given-names></name><name><surname>Li</surname><given-names>M</given-names></name><name><surname>Marín</surname><given-names>O</given-names></name><name><surname>O’Donovan</surname><given-names>MC</given-names></name><name><surname>Bray</surname><given-names>NJ</given-names></name></person-group><article-title>Single-Nuclei RNA Sequencing of 5 Regions of the Human Prenatal Brain Implicates Developing Neuron Populations in Genetic Risk for Schizophrenia</article-title><source>Biol Psychiatry</source><year>2023</year><volume>93</volume><fpage>157</fpage><lpage>166</lpage><pub-id pub-id-type="doi">10.1016/j.biopsych.2022.06.033</pub-id><pub-id pub-id-type="pmcid">PMC10804933</pub-id><pub-id pub-id-type="pmid">36150908</pub-id></element-citation></ref><ref id="R12"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Messedi</surname><given-names>M</given-names></name><name><surname>Makni-Ayadi</surname><given-names>F</given-names></name></person-group><article-title>24S-Hydroxycholesterol in Neuropsychiatric Diseases: Schizophrenia, Autism Spectrum Disorder, and Bipolar Disorder</article-title><source>Adv Exp Med Biol</source><year>2024</year><volume>1440</volume><fpage>293</fpage><lpage>304</lpage><pub-id pub-id-type="pmid">38036886</pub-id></element-citation></ref><ref id="R13"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vigne</surname><given-names>S</given-names></name><name><surname>Pot</surname><given-names>C</given-names></name></person-group><article-title>Implication of oxysterols and phytosterols in aging and human diseases</article-title><source>Adv Exp Med Biol</source><year>2024</year><volume>1440</volume><fpage>231</fpage><lpage>260</lpage><pub-id pub-id-type="pmid">38036883</pub-id></element-citation></ref><ref id="R14"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Broccoli</surname><given-names>V</given-names></name><name><surname>Caiazzo</surname><given-names>M</given-names></name></person-group><article-title>Nuclear receptors: Oxysterols detour to neurodevelopment</article-title><source>Nat Chem Biol</source><year>2013</year><volume>9</volume><fpage>70</fpage><lpage>71</lpage><pub-id pub-id-type="pmid">23334545</pub-id></element-citation></ref><ref id="R15"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Theofilopoulos</surname><given-names>S</given-names></name><name><surname>Abreu de Oliveira</surname><given-names>WA</given-names></name><name><surname>Yang</surname><given-names>S</given-names></name><name><surname>Yutuc</surname><given-names>E</given-names></name><name><surname>Saeed</surname><given-names>A</given-names></name><name><surname>Abdel-Khalik</surname><given-names>J</given-names></name><name><surname>Ullgren</surname><given-names>A</given-names></name><name><surname>Cedazo-Minguez</surname><given-names>A</given-names></name><name><surname>Björkhem</surname><given-names>I</given-names></name><name><surname>Wang</surname><given-names>Y</given-names></name><etal/></person-group><article-title>24(S),25-Epoxycholesterol and cholesterol 24S-hydroxylase (CYP46A1) overexpression promote midbrain dopaminergic neurogenesis in vivo</article-title><source>J Biol Chem</source><year>2019</year><volume>294</volume><fpage>4169</fpage><lpage>4176</lpage><pub-id pub-id-type="doi">10.1074/jbc.RA118.005639</pub-id><pub-id pub-id-type="pmcid">PMC6422085</pub-id><pub-id pub-id-type="pmid">30655290</pub-id></element-citation></ref><ref id="R16"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sacchetti</surname><given-names>P</given-names></name><name><surname>Sousa</surname><given-names>KM</given-names></name><name><surname>Hall</surname><given-names>AC</given-names></name><name><surname>Liste</surname><given-names>I</given-names></name><name><surname>Steffensen</surname><given-names>KR</given-names></name><name><surname>Theofilopoulos</surname><given-names>S</given-names></name><name><surname>Parish</surname><given-names>CL</given-names></name><name><surname>Hazenberg</surname><given-names>C</given-names></name><name><surname>Richter</surname><given-names>LA</given-names></name><name><surname>Hovatta</surname><given-names>O</given-names></name><etal/></person-group><article-title>Liver X receptors and oxysterols promote ventral midbrain neurogenesis in vivo and in human embryonic stem cells</article-title><source>Cell Stem Cell</source><year>2009</year><volume>5</volume><fpage>409</fpage><lpage>419</lpage><pub-id pub-id-type="pmid">19796621</pub-id></element-citation></ref><ref id="R17"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Sousa</surname><given-names>KM</given-names></name><name><surname>Bodin</surname><given-names>K</given-names></name><name><surname>Theofilopoulos</surname><given-names>S</given-names></name><name><surname>Sacchetti</surname><given-names>P</given-names></name><name><surname>Hornshaw</surname><given-names>M</given-names></name><name><surname>Woffendin</surname><given-names>G</given-names></name><name><surname>Karu</surname><given-names>K</given-names></name><name><surname>Sjövall</surname><given-names>J</given-names></name><name><surname>Arenas</surname><given-names>E</given-names></name><etal/></person-group><article-title>Targeted lipidomic analysis of oxysterols in the embryonic central nervous system</article-title><source>Mol Biosyst</source><year>2009</year><volume>5</volume><fpage>529</fpage><lpage>541</lpage><pub-id pub-id-type="doi">10.1039/b819502a</pub-id><pub-id pub-id-type="pmcid">PMC2702751</pub-id><pub-id pub-id-type="pmid">19381367</pub-id></element-citation></ref><ref id="R18"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>De La Fuente</surname><given-names>DC</given-names></name><name><surname>Tamburini</surname><given-names>C</given-names></name><name><surname>Stonelake</surname><given-names>E</given-names></name><name><surname>Andrews</surname><given-names>R</given-names></name><name><surname>Hall</surname><given-names>J</given-names></name><name><surname>Owen</surname><given-names>MJ</given-names></name><name><surname>Linden</surname><given-names>DEJ</given-names></name><name><surname>Pocklington</surname><given-names>A</given-names></name><name><surname>Li</surname><given-names>M</given-names></name></person-group><article-title>Impaired oxysterol-liver X receptor signaling underlies aberrant cortical neurogenesis in a stem cell model of neurodevelopmental disorder</article-title><source>Cell Rep</source><year>2024</year><volume>43</volume><elocation-id>113946</elocation-id><pub-id pub-id-type="pmid">38483902</pub-id></element-citation></ref><ref id="R19"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Raleigh</surname><given-names>DR</given-names></name><name><surname>Sever</surname><given-names>N</given-names></name><name><surname>Choksi</surname><given-names>PK</given-names></name><name><surname>Sigg</surname><given-names>MA</given-names></name><name><surname>Hines</surname><given-names>KM</given-names></name><name><surname>Thompson</surname><given-names>BM</given-names></name><name><surname>Elnatan</surname><given-names>D</given-names></name><name><surname>Jaishankar</surname><given-names>P</given-names></name><name><surname>Bisignano</surname><given-names>P</given-names></name><name><surname>Garcia-Gonzalo</surname><given-names>FR</given-names></name><etal/></person-group><article-title>Cilia-Associated Oxysterols Activate Smoothened</article-title><source>Mol Cell</source><year>2018</year><volume>72</volume><fpage>316</fpage><lpage>327</lpage><elocation-id>e5</elocation-id><pub-id pub-id-type="doi">10.1016/j.molcel.2018.08.034</pub-id><pub-id pub-id-type="pmcid">PMC6503851</pub-id><pub-id pub-id-type="pmid">30340023</pub-id></element-citation></ref><ref id="R20"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>de la Cardo</surname><given-names>LF</given-names></name><name><surname>Fuente</surname><given-names>DC</given-names></name><name><surname>Li</surname><given-names>M</given-names></name></person-group><article-title>Impaired neurogenesis and neural progenitor fate choice in a human stem cell model of SETBP1 disorder</article-title><source>Mol Autism</source><year>2023</year><volume>14</volume><fpage>8</fpage><pub-id pub-id-type="doi">10.1186/s13229-023-00540-x</pub-id><pub-id pub-id-type="pmcid">PMC9940404</pub-id><pub-id pub-id-type="pmid">36805818</pub-id></element-citation></ref><ref id="R21"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cruz</surname><given-names>MS</given-names></name><name><surname>Li</surname><given-names>M</given-names></name></person-group><article-title>Identification of TGFβ signaling as a regulator of interneuron neurogenesis in a human pluripotent stem cell model</article-title><source>Neuronal Signal</source><year>2021</year><volume>5</volume><elocation-id>NS20210020</elocation-id><pub-id pub-id-type="doi">10.1042/NS20210020</pub-id><pub-id pub-id-type="pmcid">PMC8661503</pub-id><pub-id pub-id-type="pmid">34956651</pub-id></element-citation></ref><ref id="R22"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Noakes</surname><given-names>Z</given-names></name><name><surname>Keefe</surname><given-names>F</given-names></name><name><surname>Tamburini</surname><given-names>C</given-names></name><name><surname>Kelly</surname><given-names>CM</given-names></name><name><surname>Cruz Santos</surname><given-names>M</given-names></name><name><surname>Dunnett</surname><given-names>SB</given-names></name><name><surname>Errington</surname><given-names>AC</given-names></name><name><surname>Li</surname><given-names>M</given-names></name></person-group><article-title>Human Pluripotent Stem Cell-Derived Striatal Interneurons: Differentiation and Maturation In Vitro and in the Rat Brain</article-title><source>Stem Cell Reports</source><year>2019</year><volume>12</volume><fpage>191</fpage><lpage>200</lpage><pub-id pub-id-type="doi">10.1016/j.stemcr.2018.12.014</pub-id><pub-id pub-id-type="pmcid">PMC6373547</pub-id><pub-id pub-id-type="pmid">30661995</pub-id></element-citation></ref><ref id="R23"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cruz-Santos</surname><given-names>M</given-names></name><name><surname>Cardo</surname><given-names>LF</given-names></name><name><surname>Li</surname><given-names>M</given-names></name></person-group><article-title>A Novel LHX6 Reporter Cell Line for Tracking Human iPSC-Derived Cortical Interneurons</article-title><source>Cells</source><year>2022</year><volume>11</volume><pub-id pub-id-type="doi">10.3390/cells11050853</pub-id><pub-id pub-id-type="pmcid">PMC8909769</pub-id><pub-id pub-id-type="pmid">35269475</pub-id></element-citation></ref><ref id="R24"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shi</surname><given-names>Y</given-names></name><name><surname>Wang</surname><given-names>M</given-names></name><name><surname>Mi</surname><given-names>D</given-names></name><name><surname>Lu</surname><given-names>T</given-names></name><name><surname>Wang</surname><given-names>B</given-names></name><name><surname>Dong</surname><given-names>H</given-names></name><name><surname>Zhong</surname><given-names>S</given-names></name><name><surname>Chen</surname><given-names>Y</given-names></name><name><surname>Sun</surname><given-names>L</given-names></name><name><surname>Zhou</surname><given-names>X</given-names></name><etal/></person-group><article-title>Mouse and human share conserved transcriptional programs for interneuron development</article-title><source>Science</source><year>2021</year><volume>374</volume><elocation-id>eabj6641</elocation-id><pub-id pub-id-type="pmid">34882453</pub-id></element-citation></ref><ref id="R25"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bocchi</surname><given-names>VD</given-names></name><name><surname>Conforti</surname><given-names>P</given-names></name><name><surname>Vezzoli</surname><given-names>E</given-names></name><name><surname>Besusso</surname><given-names>D</given-names></name><name><surname>Cappadona</surname><given-names>C</given-names></name><name><surname>Lischetti</surname><given-names>T</given-names></name><name><surname>Galimberti</surname><given-names>M</given-names></name><name><surname>Ranzani</surname><given-names>V</given-names></name><name><surname>Bonnal</surname><given-names>RJP</given-names></name><name><surname>De Simone</surname><given-names>M</given-names></name><etal/></person-group><article-title>The coding and long noncoding single-cell atlas of the developing human fetal striatum</article-title><source>Science</source><year>2021</year><volume>372</volume><pub-id pub-id-type="pmid">33958447</pub-id></element-citation></ref><ref id="R26"><label>26</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mayer</surname><given-names>C</given-names></name><name><surname>Hafemeister</surname><given-names>C</given-names></name><name><surname>Bandler</surname><given-names>RC</given-names></name><name><surname>Machold</surname><given-names>R</given-names></name><name><surname>Batista Brito</surname><given-names>R</given-names></name><name><surname>Jaglin</surname><given-names>X</given-names></name><name><surname>Allaway</surname><given-names>K</given-names></name><name><surname>Butler</surname><given-names>A</given-names></name><name><surname>Fishell</surname><given-names>G</given-names></name><name><surname>Satija</surname><given-names>R</given-names></name></person-group><article-title>Developmental diversification of cortical inhibitory interneurons</article-title><source>Nature</source><year>2018</year><volume>555</volume><fpage>457</fpage><lpage>462</lpage><pub-id pub-id-type="doi">10.1038/nature25999</pub-id><pub-id pub-id-type="pmcid">PMC6052457</pub-id><pub-id pub-id-type="pmid">29513653</pub-id></element-citation></ref><ref id="R27"><label>27</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Trubetskoy</surname><given-names>V</given-names></name><name><surname>Pardiñas</surname><given-names>AF</given-names></name><name><surname>Qi</surname><given-names>T</given-names></name><name><surname>Panagiotaropoulou</surname><given-names>G</given-names></name><name><surname>Awasthi</surname><given-names>S</given-names></name><name><surname>Bigdeli</surname><given-names>TB</given-names></name><name><surname>Bryois</surname><given-names>J</given-names></name><name><surname>Chen</surname><given-names>C-Y</given-names></name><name><surname>Dennison</surname><given-names>CA</given-names></name><name><surname>Hall</surname><given-names>LS</given-names></name><etal/></person-group><article-title>Mapping genomic loci implicates genes and synaptic biology in schizophrenia</article-title><source>Nature</source><year>2022</year><volume>604</volume><fpage>502</fpage><lpage>508</lpage><pub-id pub-id-type="doi">10.1038/s41586-022-04434-5</pub-id><pub-id pub-id-type="pmcid">PMC9392466</pub-id><pub-id pub-id-type="pmid">35396580</pub-id></element-citation></ref><ref id="R28"><label>28</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Savory</surname><given-names>JGA</given-names></name><name><surname>Edey</surname><given-names>C</given-names></name><name><surname>Hess</surname><given-names>B</given-names></name><name><surname>Mears</surname><given-names>AJ</given-names></name><name><surname>Lohnes</surname><given-names>D</given-names></name></person-group><article-title>Identification of novel retinoic acid target genes</article-title><source>Dev Biol</source><year>2014</year><volume>395</volume><fpage>199</fpage><lpage>208</lpage><pub-id pub-id-type="pmid">25251699</pub-id></element-citation></ref><ref id="R29"><label>29</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Willy</surname><given-names>PJ</given-names></name><name><surname>Umesono</surname><given-names>K</given-names></name><name><surname>Ong</surname><given-names>ES</given-names></name><name><surname>Evans</surname><given-names>RM</given-names></name><name><surname>Heyman</surname><given-names>RA</given-names></name><name><surname>Mangelsdorf</surname><given-names>DJ</given-names></name></person-group><article-title>LXR, a nuclear receptor that defines a distinct retinoid response pathway</article-title><source>Genes Dev</source><year>1995</year><volume>9</volume><fpage>1033</fpage><lpage>1045</lpage><pub-id pub-id-type="pmid">7744246</pub-id></element-citation></ref><ref id="R30"><label>30</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Julian</surname><given-names>LM</given-names></name><name><surname>Vandenbosch</surname><given-names>R</given-names></name><name><surname>Pakenham</surname><given-names>CA</given-names></name><name><surname>Andrusiak</surname><given-names>MG</given-names></name><name><surname>Nguyen</surname><given-names>AP</given-names></name><name><surname>McClellan</surname><given-names>KA</given-names></name><name><surname>Svoboda</surname><given-names>DS</given-names></name><name><surname>Lagace</surname><given-names>DC</given-names></name><name><surname>Park</surname><given-names>DS</given-names></name><name><surname>Leone</surname><given-names>G</given-names></name><etal/></person-group><article-title>Opposing regulation of Sox2 by cell-cycle effectors E2f3a and E2f3b in neural stem cells</article-title><source>Cell Stem Cell</source><year>2013</year><volume>12</volume><fpage>440</fpage><lpage>452</lpage><pub-id pub-id-type="pmid">23499385</pub-id></element-citation></ref><ref id="R31"><label>31</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dhanesh</surname><given-names>SB</given-names></name><name><surname>Subashini</surname><given-names>C</given-names></name><name><surname>James</surname><given-names>J</given-names></name></person-group><article-title>Hes1: the maestro in neurogenesis</article-title><source>Cell Mol Life Sci</source><year>2016</year><volume>73</volume><fpage>4019</fpage><lpage>4042</lpage><pub-id pub-id-type="doi">10.1007/s00018-016-2277-z</pub-id><pub-id pub-id-type="pmcid">PMC11108451</pub-id><pub-id pub-id-type="pmid">27233500</pub-id></element-citation></ref><ref id="R32"><label>32</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Singh</surname><given-names>A</given-names></name><name><surname>Mahesh</surname><given-names>A</given-names></name><name><surname>Noack</surname><given-names>F</given-names></name><name><surname>Cardoso de Toledo</surname><given-names>B</given-names></name><name><surname>Calegari</surname><given-names>F</given-names></name><name><surname>Tiwari</surname><given-names>VK</given-names></name></person-group><article-title>Tcf12 and NeuroD1 cooperatively drive neuronal migration during cortical development</article-title><source>Development</source><year>2022</year><volume>149</volume><pub-id pub-id-type="doi">10.1242/dev.200250</pub-id><pub-id pub-id-type="pmcid">PMC8918803</pub-id><pub-id pub-id-type="pmid">35147187</pub-id></element-citation></ref><ref id="R33"><label>33</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kuwahara</surname><given-names>A</given-names></name><name><surname>Sakai</surname><given-names>H</given-names></name><name><surname>Xu</surname><given-names>Y</given-names></name><name><surname>Itoh</surname><given-names>Y</given-names></name><name><surname>Hirabayashi</surname><given-names>Y</given-names></name><name><surname>Gotoh</surname><given-names>Y</given-names></name></person-group><article-title>Tcf3 represses Wnt-β-catenin signaling and maintains neural stem cell population during neocortical development</article-title><source>PLoS ONE</source><year>2014</year><volume>9</volume><elocation-id>e94408</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0094408</pub-id><pub-id pub-id-type="pmcid">PMC4022625</pub-id><pub-id pub-id-type="pmid">24832538</pub-id></element-citation></ref><ref id="R34"><label>34</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hiew</surname><given-names>L-F</given-names></name><name><surname>Poon</surname><given-names>C-H</given-names></name><name><surname>You</surname><given-names>H-Z</given-names></name><name><surname>Lim</surname><given-names>L-W</given-names></name></person-group><article-title>TGF-β/Smad Signalling in Neurogenesis: Implications for Neuropsychiatric Diseases</article-title><source>Cells</source><year>2021</year><volume>10</volume><pub-id pub-id-type="doi">10.3390/cells10061382</pub-id><pub-id pub-id-type="pmcid">PMC8226492</pub-id><pub-id pub-id-type="pmid">34205102</pub-id></element-citation></ref><ref id="R35"><label>35</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ballas</surname><given-names>N</given-names></name><name><surname>Grunseich</surname><given-names>C</given-names></name><name><surname>Lu</surname><given-names>DD</given-names></name><name><surname>Speh</surname><given-names>JC</given-names></name><name><surname>Mandel</surname><given-names>G</given-names></name></person-group><article-title>REST and its corepressors mediate plasticity of neuronal gene chromatin throughout neurogenesis</article-title><source>Cell</source><year>2005</year><volume>121</volume><fpage>645</fpage><lpage>657</lpage><pub-id pub-id-type="pmid">15907476</pub-id></element-citation></ref><ref id="R36"><label>36</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zurkirchen</surname><given-names>L</given-names></name><name><surname>Varum</surname><given-names>S</given-names></name><name><surname>Giger</surname><given-names>S</given-names></name><name><surname>Klug</surname><given-names>A</given-names></name><name><surname>Häusel</surname><given-names>J</given-names></name><name><surname>Bossart</surname><given-names>R</given-names></name><name><surname>Zemke</surname><given-names>M</given-names></name><name><surname>Cantù</surname><given-names>C</given-names></name><name><surname>Atak</surname><given-names>ZK</given-names></name><name><surname>Zamboni</surname><given-names>N</given-names></name><etal/></person-group><article-title>Yin Yang 1 sustains biosynthetic demands during brain development in a stage-specific manner</article-title><source>Nat Commun</source><year>2019</year><volume>10</volume><elocation-id>2192</elocation-id><pub-id pub-id-type="doi">10.1038/s41467-019-09823-5</pub-id><pub-id pub-id-type="pmcid">PMC6522535</pub-id><pub-id pub-id-type="pmid">31097699</pub-id></element-citation></ref><ref id="R37"><label>37</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lehmann</surname><given-names>JM</given-names></name><name><surname>Kliewer</surname><given-names>SA</given-names></name><name><surname>Moore</surname><given-names>LB</given-names></name><name><surname>Smith-Oliver</surname><given-names>TA</given-names></name><name><surname>Oliver</surname><given-names>BB</given-names></name><name><surname>Su</surname><given-names>JL</given-names></name><name><surname>Sundseth</surname><given-names>SS</given-names></name><name><surname>Winegar</surname><given-names>DA</given-names></name><name><surname>Blanchard</surname><given-names>DE</given-names></name><name><surname>Spencer</surname><given-names>TA</given-names></name><etal/></person-group><article-title>Activation of the nuclear receptor LXR by oxysterols defines a new hormone response pathway</article-title><source>J Biol Chem</source><year>1997</year><volume>272</volume><fpage>3137</fpage><lpage>3140</lpage><pub-id pub-id-type="pmid">9013544</pub-id></element-citation></ref><ref id="R38"><label>38</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Leoni</surname><given-names>V</given-names></name><name><surname>Caccia</surname><given-names>C</given-names></name></person-group><article-title>Oxysterols as biomarkers in neurodegenerative diseases</article-title><source>Chem Phys Lipids</source><year>2011</year><volume>164</volume><fpage>515</fpage><lpage>524</lpage><pub-id pub-id-type="pmid">21515244</pub-id></element-citation></ref><ref id="R39"><label>39</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gamba</surname><given-names>P</given-names></name><name><surname>Testa</surname><given-names>G</given-names></name><name><surname>Sottero</surname><given-names>B</given-names></name><name><surname>Gargiulo</surname><given-names>S</given-names></name><name><surname>Poli</surname><given-names>G</given-names></name><name><surname>Leonarduzzi</surname><given-names>G</given-names></name></person-group><article-title>The link between altered cholesterol metabolism and Alzheimer’s disease</article-title><source>Ann N Y Acad Sci</source><year>2012</year><volume>1259</volume><fpage>54</fpage><lpage>64</lpage><pub-id pub-id-type="pmid">22758637</pub-id></element-citation></ref><ref id="R40"><label>40</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jin</surname><given-names>U</given-names></name><name><surname>Park</surname><given-names>SJ</given-names></name><name><surname>Park</surname><given-names>SM</given-names></name></person-group><article-title>Cholesterol Metabolism in the Brain and Its Association with Parkinson’s Disease</article-title><source>Exp Neurobiol</source><year>2019</year><volume>28</volume><fpage>554</fpage><lpage>567</lpage><pub-id pub-id-type="doi">10.5607/en.2019.28.5.554</pub-id><pub-id pub-id-type="pmcid">PMC6844833</pub-id><pub-id pub-id-type="pmid">31698548</pub-id></element-citation></ref><ref id="R41"><label>41</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Karasinska</surname><given-names>JM</given-names></name><name><surname>Hayden</surname><given-names>MR</given-names></name></person-group><article-title>Cholesterol metabolism in Huntington disease</article-title><source>Nat Rev Neurol</source><year>2011</year><volume>7</volume><fpage>561</fpage><lpage>572</lpage><pub-id pub-id-type="pmid">21894212</pub-id></element-citation></ref><ref id="R42"><label>42</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sun</surname><given-names>Z</given-names></name><name><surname>Zhao</surname><given-names>L</given-names></name><name><surname>Bo</surname><given-names>Q</given-names></name><name><surname>Mao</surname><given-names>Z</given-names></name><name><surname>He</surname><given-names>Y</given-names></name><name><surname>Jiang</surname><given-names>T</given-names></name><name><surname>Li</surname><given-names>Y</given-names></name><name><surname>Wang</surname><given-names>C</given-names></name><name><surname>Li</surname><given-names>R</given-names></name></person-group><article-title>Brain-Specific Oxysterols and Risk of Schizophrenia in Clinical High-Risk Subjects and Patients With Schizophrenia</article-title><source>Front Psychiatry</source><year>2021</year><volume>12</volume><elocation-id>711734</elocation-id><pub-id pub-id-type="doi">10.3389/fpsyt.2021.711734</pub-id><pub-id pub-id-type="pmcid">PMC8367079</pub-id><pub-id pub-id-type="pmid">34408685</pub-id></element-citation></ref><ref id="R43"><label>43</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Grayaa</surname><given-names>S</given-names></name><name><surname>Zerbinati</surname><given-names>C</given-names></name><name><surname>Messedi</surname><given-names>M</given-names></name><name><surname>HadjKacem</surname><given-names>I</given-names></name><name><surname>Chtourou</surname><given-names>M</given-names></name><name><surname>Ben Touhemi</surname><given-names>D</given-names></name><name><surname>Naifar</surname><given-names>M</given-names></name><name><surname>Ayadi</surname><given-names>H</given-names></name><name><surname>Ayedi</surname><given-names>F</given-names></name><name><surname>Iuliano</surname><given-names>L</given-names></name></person-group><article-title>Plasma oxysterol profiling in children reveals 24-hydroxycholesterol as a potential marker for Autism Spectrum Disorders</article-title><source>Biochimie</source><year>2018</year><volume>153</volume><fpage>80</fpage><lpage>85</lpage><pub-id pub-id-type="pmid">29730299</pub-id></element-citation></ref><ref id="R44"><label>44</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guidara</surname><given-names>W</given-names></name><name><surname>Messedi</surname><given-names>M</given-names></name><name><surname>Maalej</surname><given-names>M</given-names></name><name><surname>Naifar</surname><given-names>M</given-names></name><name><surname>Khrouf</surname><given-names>W</given-names></name><name><surname>Grayaa</surname><given-names>S</given-names></name><name><surname>Maalej</surname><given-names>M</given-names></name><name><surname>Bonnefont-Rousselot</surname><given-names>D</given-names></name><name><surname>Lamari</surname><given-names>F</given-names></name><name><surname>Ayadi</surname><given-names>F</given-names></name></person-group><article-title>Plasma oxysterols: Altered level of plasma 24-hydroxycholesterol in patients with bipolar disorder</article-title><source>J Steroid Biochem Mol Biol</source><year>2021</year><volume>211</volume><elocation-id>105902</elocation-id><pub-id pub-id-type="pmid">33901658</pub-id></element-citation></ref><ref id="R45"><label>45</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kessaris</surname><given-names>N</given-names></name><name><surname>Magno</surname><given-names>L</given-names></name><name><surname>Rubin</surname><given-names>AN</given-names></name><name><surname>Oliveira</surname><given-names>MG</given-names></name></person-group><article-title>Genetic programs controlling cortical interneuron fate</article-title><source>Curr Opin Neurobiol</source><year>2014</year><volume>26</volume><fpage>79</fpage><lpage>87</lpage><pub-id pub-id-type="doi">10.1016/j.conb.2013.12.012</pub-id><pub-id pub-id-type="pmcid">PMC4082532</pub-id><pub-id pub-id-type="pmid">24440413</pub-id></element-citation></ref><ref id="R46"><label>46</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mi</surname><given-names>D</given-names></name><name><surname>Li</surname><given-names>Z</given-names></name><name><surname>Lim</surname><given-names>L</given-names></name><name><surname>Li</surname><given-names>M</given-names></name><name><surname>Moissidis</surname><given-names>M</given-names></name><name><surname>Yang</surname><given-names>Y</given-names></name><name><surname>Gao</surname><given-names>T</given-names></name><name><surname>Hu</surname><given-names>TX</given-names></name><name><surname>Pratt</surname><given-names>T</given-names></name><name><surname>Price</surname><given-names>DJ</given-names></name><etal/></person-group><article-title>Early emergence of cortical interneuron diversity in the mouse embryo</article-title><source>Science</source><year>2018</year><volume>360</volume><fpage>81</fpage><lpage>85</lpage><pub-id pub-id-type="doi">10.1126/science.aar6821</pub-id><pub-id pub-id-type="pmcid">PMC6195193</pub-id><pub-id pub-id-type="pmid">29472441</pub-id></element-citation></ref><ref id="R47"><label>47</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Inan</surname><given-names>M</given-names></name><name><surname>Welagen</surname><given-names>J</given-names></name><name><surname>Anderson</surname><given-names>SA</given-names></name></person-group><article-title>Spatial and temporal bias in the mitotic origins of somatostatin- and parvalbumin-expressing interneuron subgroups and the chandelier subtype in the medial ganglionic eminence</article-title><source>Cereb Cortex</source><year>2012</year><volume>22</volume><fpage>820</fpage><lpage>827</lpage><pub-id pub-id-type="doi">10.1093/cercor/bhr148</pub-id><pub-id pub-id-type="pmcid">PMC3450921</pub-id><pub-id pub-id-type="pmid">21693785</pub-id></element-citation></ref><ref id="R48"><label>48</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Miyoshi</surname><given-names>G</given-names></name><name><surname>Hjerling-Leffler</surname><given-names>J</given-names></name><name><surname>Karayannis</surname><given-names>T</given-names></name><name><surname>Sousa</surname><given-names>VH</given-names></name><name><surname>Butt</surname><given-names>SJB</given-names></name><name><surname>Battiste</surname><given-names>J</given-names></name><name><surname>Johnson</surname><given-names>JE</given-names></name><name><surname>Machold</surname><given-names>RP</given-names></name><name><surname>Fishell</surname><given-names>G</given-names></name></person-group><article-title>Genetic fate mapping reveals that the caudal ganglionic eminence produces a large and diverse population of superficial cortical interneurons</article-title><source>J Neurosci</source><year>2010</year><volume>30</volume><fpage>1582</fpage><lpage>1594</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.4515-09.2010</pub-id><pub-id pub-id-type="pmcid">PMC2826846</pub-id><pub-id pub-id-type="pmid">20130169</pub-id></element-citation></ref><ref id="R49"><label>49</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Miyoshi</surname><given-names>G</given-names></name><name><surname>Butt</surname><given-names>SJB</given-names></name><name><surname>Takebayashi</surname><given-names>H</given-names></name><name><surname>Fishell</surname><given-names>G</given-names></name></person-group><article-title>Physiologically distinct temporal cohorts of cortical interneurons arise from telencephalic Olig2-expressing precursors</article-title><source>J Neurosci</source><year>2007</year><volume>27</volume><fpage>7786</fpage><lpage>7798</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.1807-07.2007</pub-id><pub-id pub-id-type="pmcid">PMC6672881</pub-id><pub-id pub-id-type="pmid">17634372</pub-id></element-citation></ref><ref id="R50"><label>50</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ma</surname><given-names>L</given-names></name><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Hui</surname><given-names>Y</given-names></name><name><surname>Du</surname><given-names>Y</given-names></name><name><surname>Chen</surname><given-names>Z</given-names></name><name><surname>Feng</surname><given-names>H</given-names></name><name><surname>Zhang</surname><given-names>S</given-names></name><name><surname>Li</surname><given-names>N</given-names></name><name><surname>Song</surname><given-names>J</given-names></name><name><surname>Fang</surname><given-names>Y</given-names></name><etal/></person-group><article-title>WNT/NOTCH pathway is essential for the maintenance and expansion of human MGE progenitors</article-title><source>Stem Cell Reports</source><year>2019</year><volume>12</volume><fpage>934</fpage><lpage>949</lpage><pub-id pub-id-type="doi">10.1016/j.stemcr.2019.04.007</pub-id><pub-id pub-id-type="pmcid">PMC6524734</pub-id><pub-id pub-id-type="pmid">31056478</pub-id></element-citation></ref><ref id="R51"><label>51</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chenn</surname><given-names>A</given-names></name><name><surname>Walsh</surname><given-names>CA</given-names></name></person-group><article-title>Regulation of cerebral cortical size by control of cell cycle exit in neural precursors</article-title><source>Science</source><year>2002</year><volume>297</volume><fpage>365</fpage><lpage>369</lpage><pub-id pub-id-type="pmid">12130776</pub-id></element-citation></ref><ref id="R52"><label>52</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Viti</surname><given-names>J</given-names></name><name><surname>Gulacsi</surname><given-names>A</given-names></name><name><surname>Lillien</surname><given-names>L</given-names></name></person-group><article-title>Wnt regulation of progenitor maturation in the cortex depends on Shh or fibroblast growth factor 2</article-title><source>J Neurosci</source><year>2003</year><volume>23</volume><fpage>5919</fpage><lpage>5927</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.23-13-05919.2003</pub-id><pub-id pub-id-type="pmcid">PMC6741239</pub-id><pub-id pub-id-type="pmid">12843296</pub-id></element-citation></ref><ref id="R53"><label>53</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zechner</surname><given-names>D</given-names></name><name><surname>Fujita</surname><given-names>Y</given-names></name><name><surname>Hülsken</surname><given-names>J</given-names></name><name><surname>Müller</surname><given-names>T</given-names></name><name><surname>Walther</surname><given-names>I</given-names></name><name><surname>Taketo</surname><given-names>MM</given-names></name><name><surname>Crenshaw</surname><given-names>EB</given-names></name><name><surname>Birchmeier</surname><given-names>W</given-names></name><name><surname>Birchmeier</surname><given-names>C</given-names></name></person-group><article-title>beta-Catenin signals regulate cell growth and the balance between progenitor cell expansion and differentiation in the nervous system</article-title><source>Dev Biol</source><year>2003</year><volume>258</volume><fpage>406</fpage><lpage>418</lpage><pub-id pub-id-type="pmid">12798297</pub-id></element-citation></ref><ref id="R54"><label>54</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Israsena</surname><given-names>N</given-names></name><name><surname>Hu</surname><given-names>M</given-names></name><name><surname>Fu</surname><given-names>W</given-names></name><name><surname>Kan</surname><given-names>L</given-names></name><name><surname>Kessler</surname><given-names>JA</given-names></name></person-group><article-title>The presence of FGF2 signaling determines whether beta-catenin exerts effects on proliferation or neuronal differentiation of neural stem cells</article-title><source>Dev Biol</source><year>2004</year><volume>268</volume><fpage>220</fpage><lpage>231</lpage><pub-id pub-id-type="pmid">15031118</pub-id></element-citation></ref><ref id="R55"><label>55</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hirabayashi</surname><given-names>Y</given-names></name><name><surname>Itoh</surname><given-names>Y</given-names></name><name><surname>Tabata</surname><given-names>H</given-names></name><name><surname>Nakajima</surname><given-names>K</given-names></name><name><surname>Akiyama</surname><given-names>T</given-names></name><name><surname>Masuyama</surname><given-names>N</given-names></name><name><surname>Gotoh</surname><given-names>Y</given-names></name></person-group><article-title>The Wnt/beta-catenin pathway directs neuronal differentiation of cortical neural precursor cells</article-title><source>Development</source><year>2004</year><volume>131</volume><fpage>2791</fpage><lpage>2801</lpage><pub-id pub-id-type="pmid">15142975</pub-id></element-citation></ref><ref id="R56"><label>56</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kuwabara</surname><given-names>T</given-names></name><name><surname>Hsieh</surname><given-names>J</given-names></name><name><surname>Muotri</surname><given-names>A</given-names></name><name><surname>Yeo</surname><given-names>G</given-names></name><name><surname>Warashina</surname><given-names>M</given-names></name><name><surname>Lie</surname><given-names>DC</given-names></name><name><surname>Moore</surname><given-names>L</given-names></name><name><surname>Nakashima</surname><given-names>K</given-names></name><name><surname>Asashima</surname><given-names>M</given-names></name><name><surname>Gage</surname><given-names>FH</given-names></name></person-group><article-title>Wnt-mediated activation of NeuroD1 and retro-elements during adult neurogenesis</article-title><source>Nat Neurosci</source><year>2009</year><volume>12</volume><fpage>1097</fpage><lpage>1105</lpage><pub-id pub-id-type="doi">10.1038/nn.2360</pub-id><pub-id pub-id-type="pmcid">PMC2764260</pub-id><pub-id pub-id-type="pmid">19701198</pub-id></element-citation></ref><ref id="R57"><label>57</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tyson</surname><given-names>JA</given-names></name><name><surname>Anderson</surname><given-names>SA</given-names></name></person-group><article-title>GABAergic interneuron transplants to study development and treat disease</article-title><source>Trends Neurosci</source><year>2014</year><volume>37</volume><fpage>169</fpage><lpage>177</lpage><pub-id pub-id-type="doi">10.1016/j.tins.2014.01.003</pub-id><pub-id pub-id-type="pmcid">PMC4396846</pub-id><pub-id pub-id-type="pmid">24508416</pub-id></element-citation></ref><ref id="R58"><label>58</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Southwell</surname><given-names>DG</given-names></name><name><surname>Froemke</surname><given-names>RC</given-names></name><name><surname>Alvarez-Buylla</surname><given-names>A</given-names></name><name><surname>Stryker</surname><given-names>MP</given-names></name><name><surname>Gandhi</surname><given-names>SP</given-names></name></person-group><article-title>Cortical plasticity induced by inhibitory neuron transplantation</article-title><source>Science</source><year>2010</year><volume>327</volume><fpage>1145</fpage><lpage>1148</lpage><pub-id pub-id-type="doi">10.1126/science.1183962</pub-id><pub-id pub-id-type="pmcid">PMC3164148</pub-id><pub-id pub-id-type="pmid">20185728</pub-id></element-citation></ref><ref id="R59"><label>59</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maisano</surname><given-names>X</given-names></name><name><surname>Litvina</surname><given-names>E</given-names></name><name><surname>Tagliatela</surname><given-names>S</given-names></name><name><surname>Aaron</surname><given-names>GB</given-names></name><name><surname>Grabel</surname><given-names>LB</given-names></name><name><surname>Naegele</surname><given-names>JR</given-names></name></person-group><article-title>Differentiation and functional incorporation of embryonic stem cell-derived GABAergic interneurons in the dentate gyrus of mice with temporal lobe epilepsy</article-title><source>J Neurosci</source><year>2012</year><volume>32</volume><fpage>46</fpage><lpage>61</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.2683-11.2012</pub-id><pub-id pub-id-type="pmcid">PMC3548598</pub-id><pub-id pub-id-type="pmid">22219269</pub-id></element-citation></ref><ref id="R60"><label>60</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>Y</given-names></name><name><surname>Weick</surname><given-names>JP</given-names></name><name><surname>Liu</surname><given-names>H</given-names></name><name><surname>Krencik</surname><given-names>R</given-names></name><name><surname>Zhang</surname><given-names>X</given-names></name><name><surname>Ma</surname><given-names>L</given-names></name><name><surname>Zhou</surname><given-names>G</given-names></name><name><surname>Ayala</surname><given-names>M</given-names></name><name><surname>Zhang</surname><given-names>S-C</given-names></name></person-group><article-title>Medial ganglionic eminence-like cells derived from human embryonic stem cells correct learning and memory deficits</article-title><source>Nat Biotechnol</source><year>2013</year><volume>31</volume><fpage>440</fpage><lpage>447</lpage><pub-id pub-id-type="doi">10.1038/nbt.2565</pub-id><pub-id pub-id-type="pmcid">PMC3711863</pub-id><pub-id pub-id-type="pmid">23604284</pub-id></element-citation></ref><ref id="R61"><label>61</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pantazis</surname><given-names>CB</given-names></name><name><surname>Yang</surname><given-names>A</given-names></name><name><surname>Lara</surname><given-names>E</given-names></name><name><surname>McDonough</surname><given-names>JA</given-names></name><name><surname>Blauwendraat</surname><given-names>C</given-names></name><name><surname>Peng</surname><given-names>L</given-names></name><name><surname>Oguro</surname><given-names>H</given-names></name><name><surname>Kanaujiya</surname><given-names>J</given-names></name><name><surname>Zou</surname><given-names>J</given-names></name><name><surname>Sebesta</surname><given-names>D</given-names></name><etal/></person-group><article-title>A reference human induced pluripotent stem cell line for large-scale collaborative studies</article-title><source>Cell Stem Cell</source><year>2022</year><volume>29</volume><fpage>1685</fpage><lpage>1702</lpage><elocation-id>e22</elocation-id><pub-id pub-id-type="doi">10.1016/j.stem.2022.11.004</pub-id><pub-id pub-id-type="pmcid">PMC9782786</pub-id><pub-id pub-id-type="pmid">36459969</pub-id></element-citation></ref><ref id="R62"><label>62</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hao</surname><given-names>Y</given-names></name><name><surname>Stuart</surname><given-names>T</given-names></name><name><surname>Kowalski</surname><given-names>MH</given-names></name><name><surname>Choudhary</surname><given-names>S</given-names></name><name><surname>Hoffman</surname><given-names>P</given-names></name><name><surname>Hartman</surname><given-names>A</given-names></name><name><surname>Srivastava</surname><given-names>A</given-names></name><name><surname>Molla</surname><given-names>G</given-names></name><name><surname>Madad</surname><given-names>S</given-names></name><name><surname>Fernandez-Granda</surname><given-names>C</given-names></name><etal/></person-group><article-title>Dictionary learning for integrative, multimodal and scalable single-cell analysis</article-title><source>Nat Biotechnol</source><year>2024</year><volume>42</volume><fpage>293</fpage><lpage>304</lpage><pub-id pub-id-type="doi">10.1038/s41587-023-01767-y</pub-id><pub-id pub-id-type="pmcid">PMC10928517</pub-id><pub-id pub-id-type="pmid">37231261</pub-id></element-citation></ref><ref id="R63"><label>63</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McCarthy</surname><given-names>DJ</given-names></name><name><surname>Campbell</surname><given-names>KR</given-names></name><name><surname>Lun</surname><given-names>ATL</given-names></name><name><surname>Wills</surname><given-names>QF</given-names></name></person-group><article-title>Scater: pre-processing, quality control, normalization and visualization of single-cell RNA-seq data in R</article-title><source>Bioinformatics</source><year>2017</year><volume>33</volume><fpage>1179</fpage><lpage>1186</lpage><pub-id pub-id-type="doi">10.1093/bioinformatics/btw777</pub-id><pub-id pub-id-type="pmcid">PMC5408845</pub-id><pub-id pub-id-type="pmid">28088763</pub-id></element-citation></ref><ref id="R64"><label>64</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Choudhary</surname><given-names>S</given-names></name><name><surname>Satija</surname><given-names>R</given-names></name></person-group><article-title>Comparison and evaluation of statistical error models for scRNA-seq</article-title><source>Genome Biol</source><year>2022</year><volume>23</volume><fpage>27</fpage><pub-id pub-id-type="doi">10.1186/s13059-021-02584-9</pub-id><pub-id pub-id-type="pmcid">PMC8764781</pub-id><pub-id pub-id-type="pmid">35042561</pub-id></element-citation></ref><ref id="R65"><label>65</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Korsunsky</surname><given-names>I</given-names></name><name><surname>Millard</surname><given-names>N</given-names></name><name><surname>Fan</surname><given-names>J</given-names></name><name><surname>Slowikowski</surname><given-names>K</given-names></name><name><surname>Zhang</surname><given-names>F</given-names></name><name><surname>Wei</surname><given-names>K</given-names></name><name><surname>Baglaenko</surname><given-names>Y</given-names></name><name><surname>Brenner</surname><given-names>M</given-names></name><name><surname>Loh</surname><given-names>P-R</given-names></name><name><surname>Raychaudhuri</surname><given-names>S</given-names></name></person-group><article-title>Fast, sensitive and accurate integration of single-cell data with Harmony</article-title><source>Nat Methods</source><year>2019</year><volume>16</volume><fpage>1289</fpage><lpage>1296</lpage><pub-id pub-id-type="doi">10.1038/s41592-019-0619-0</pub-id><pub-id pub-id-type="pmcid">PMC6884693</pub-id><pub-id pub-id-type="pmid">31740819</pub-id></element-citation></ref><ref id="R66"><label>66</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nestorowa</surname><given-names>S</given-names></name><name><surname>Hamey</surname><given-names>FK</given-names></name><name><surname>Pijuan Sala</surname><given-names>B</given-names></name><name><surname>Diamanti</surname><given-names>E</given-names></name><name><surname>Shepherd</surname><given-names>M</given-names></name><name><surname>Laurenti</surname><given-names>E</given-names></name><name><surname>Wilson</surname><given-names>NK</given-names></name><name><surname>Kent</surname><given-names>DG</given-names></name><name><surname>Göttgens</surname><given-names>B</given-names></name></person-group><article-title>A single-cell resolution map of mouse hematopoietic stem and progenitor cell differentiation</article-title><source>Blood</source><year>2016</year><volume>128</volume><fpage>e20</fpage><lpage>31</lpage><pub-id pub-id-type="doi">10.1182/blood-2016-05-716480</pub-id><pub-id pub-id-type="pmcid">PMC5305050</pub-id><pub-id pub-id-type="pmid">27365425</pub-id></element-citation></ref><ref id="R67"><label>67</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hinshaw</surname><given-names>DC</given-names></name><name><surname>Shevde</surname><given-names>LA</given-names></name></person-group><article-title>The tumor microenvironment innately modulates cancer progression</article-title><source>Cancer Res</source><year>2019</year><volume>79</volume><fpage>4557</fpage><lpage>4566</lpage><pub-id pub-id-type="doi">10.1158/0008-5472.CAN-18-3962</pub-id><pub-id pub-id-type="pmcid">PMC6744958</pub-id><pub-id pub-id-type="pmid">31350295</pub-id></element-citation></ref><ref id="R68"><label>68</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yu</surname><given-names>G</given-names></name><name><surname>Wang</surname><given-names>L-G</given-names></name><name><surname>Han</surname><given-names>Y</given-names></name><name><surname>He</surname><given-names>Q-Y</given-names></name></person-group><article-title>clusterProfiler: an R package for comparing biological themes among gene clusters</article-title><source>OMICS</source><year>2012</year><volume>16</volume><fpage>284</fpage><lpage>287</lpage><pub-id pub-id-type="doi">10.1089/omi.2011.0118</pub-id><pub-id pub-id-type="pmcid">PMC3339379</pub-id><pub-id pub-id-type="pmid">22455463</pub-id></element-citation></ref><ref id="R69"><label>69</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aibar</surname><given-names>S</given-names></name><name><surname>González-Blas</surname><given-names>CB</given-names></name><name><surname>Moerman</surname><given-names>T</given-names></name><name><surname>Huynh-Thu</surname><given-names>VA</given-names></name><name><surname>Imrichova</surname><given-names>H</given-names></name><name><surname>Hulselmans</surname><given-names>G</given-names></name><name><surname>Rambow</surname><given-names>F</given-names></name><name><surname>Marine</surname><given-names>J-C</given-names></name><name><surname>Geurts</surname><given-names>P</given-names></name><name><surname>Aerts</surname><given-names>J</given-names></name><etal/></person-group><article-title>SCENIC: single-cell regulatory network inference and clustering</article-title><source>Nat Methods</source><year>2017</year><volume>14</volume><fpage>1083</fpage><lpage>1086</lpage><pub-id pub-id-type="doi">10.1038/nmeth.4463</pub-id><pub-id pub-id-type="pmcid">PMC5937676</pub-id><pub-id pub-id-type="pmid">28991892</pub-id></element-citation></ref><ref id="R70"><label>70</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Van de Sande</surname><given-names>B</given-names></name><name><surname>Flerin</surname><given-names>C</given-names></name><name><surname>Davie</surname><given-names>K</given-names></name><name><surname>De Waegeneer</surname><given-names>M</given-names></name><name><surname>Hulselmans</surname><given-names>G</given-names></name><name><surname>Aibar</surname><given-names>S</given-names></name><name><surname>Seurinck</surname><given-names>R</given-names></name><name><surname>Saelens</surname><given-names>W</given-names></name><name><surname>Cannoodt</surname><given-names>R</given-names></name><name><surname>Rouchon</surname><given-names>Q</given-names></name><etal/></person-group><article-title>A scalable SCENIC workflow for single-cell gene regulatory network analysis</article-title><source>Nat Protoc</source><year>2020</year><volume>15</volume><fpage>2247</fpage><lpage>2276</lpage><pub-id pub-id-type="pmid">32561888</pub-id></element-citation></ref><ref id="R71"><label>71</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shannon</surname><given-names>P</given-names></name><name><surname>Markiel</surname><given-names>A</given-names></name><name><surname>Ozier</surname><given-names>O</given-names></name><name><surname>Baliga</surname><given-names>NS</given-names></name><name><surname>Wang</surname><given-names>JT</given-names></name><name><surname>Ramage</surname><given-names>D</given-names></name><name><surname>Amin</surname><given-names>N</given-names></name><name><surname>Schwikowski</surname><given-names>B</given-names></name><name><surname>Ideker</surname><given-names>T</given-names></name></person-group><article-title>Cytoscape: a software environment for integrated models of biomolecular interaction networks</article-title><source>Genome Res</source><year>2003</year><volume>13</volume><fpage>2498</fpage><lpage>2504</lpage><pub-id pub-id-type="doi">10.1101/gr.1239303</pub-id><pub-id pub-id-type="pmcid">PMC403769</pub-id><pub-id pub-id-type="pmid">14597658</pub-id></element-citation></ref><ref id="R72"><label>72</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Murphy</surname><given-names>AE</given-names></name><name><surname>Schilder</surname><given-names>BM</given-names></name><name><surname>Skene</surname><given-names>NG</given-names></name></person-group><article-title>MungeSumstats: a Bioconductor package for the standardization and quality control of many GWAS summary statistics</article-title><source>Bioinformatics</source><year>2021</year><volume>37</volume><fpage>4593</fpage><lpage>4596</lpage><pub-id pub-id-type="doi">10.1093/bioinformatics/btab665</pub-id><pub-id pub-id-type="pmcid">PMC8652100</pub-id><pub-id pub-id-type="pmid">34601555</pub-id></element-citation></ref><ref id="R73"><label>73</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>de Leeuw</surname><given-names>CA</given-names></name><name><surname>Mooij</surname><given-names>JM</given-names></name><name><surname>Heskes</surname><given-names>T</given-names></name><name><surname>Posthuma</surname><given-names>D</given-names></name></person-group><article-title>MAGMA: generalized gene-set analysis of GWAS data</article-title><source>PLoS Comput Biol</source><year>2015</year><volume>11</volume><elocation-id>e1004219</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pcbi.1004219</pub-id><pub-id pub-id-type="pmcid">PMC4401657</pub-id><pub-id pub-id-type="pmid">25885710</pub-id></element-citation></ref></ref-list></back><floats-group><fig id="F1" position="float"><label>Figure 1</label><caption><title>24S, 25-EC promotes neuronal production from NKX2.1<sup>+</sup> progenitors</title><p>A) Outline of the neural differentiation paradigm and 24S, 25-EC treatment regime. B) Endogenous mEmerald signal from the LHX6-mEmerald cultures treated with vehicle or 24S, 25-EC (EC) at d25, d30 and d45. C) Quantification of mEmerald<sup>+</sup> cells from d25-d55. D) Top and middle rows, triple immunostaining for NKX2.1(green), OLIG2 (red), and COUPTF2 (magenta) and single staining for FOXG1 (green) at d25 of differentiation. E) Quantification of NKX2.1<sup>+</sup>, FOXG1<sup>+</sup>, OLIG2<sup>+</sup> and COUPTF2<sup>+</sup> cells shown in D. F) Double immunostaining for NKX2.1 (green) and Ki67 (light blue) combined with EdU labelling (red). Arrow heads indicate NKX2.1<sup>+</sup>EdU<sup>+</sup>Ki67<sup>-</sup> cells. G) Quantification of cycling NKX2.1<sup>+</sup> Ki67<sup>+</sup> progenitors. H) Quantification of cell cycle exit index. Data presented are mean ± s.e.m. of three independent differentiation runs each with 2-3 technical replicates. Each dot in the graphs represents an image counted. The numbers of technical replicates and images counted in C, E G, H are provided in <xref ref-type="supplementary-material" rid="SD1">table S4</xref>. EC treated vs vehicle control groups were compared by two-way ANOVA with post-hoc Bonferroni in C. One-way ANOVA with post-hoc Dunnett T3 or non-parametric Kruskal-Wallis with post-hoc Dunn in E. One-way ANOVA with post-hoc Bonferroni in G or Dunnett T3 in H (*p&lt;0.05; **p&lt;0.01; ***p&lt;0.001). Nuclei were counterstained with DAPI (blue) or Hoechst for live imaging in B. Scale bars: 100 µm.</p></caption><graphic xlink:href="EMS207079-f001"/></fig><fig id="F2" position="float"><label>Figure 2</label><caption><title>Single cell RNAseq confirms highly specific MGE fate induction</title><p>A) UMAP embedding of scRNA-seq data of 58,066 control and 56,721 EC-treated iPSC-derived MGE cells at d25 and d40. B) UMAP of control cells only at d25 and d40. C) Stack plot depicting quantification of d25 and d40 in each cell cluster of the control samples. D) UMAP plot of control cells color-coded by predicted cell cycle phases. E) The proportion of control cells in each cell cycle phase at d25 and d40. F) Feature plots showing the expression levels of brain-region-specific genes. G) Sankey diagram showing alignment of iPSC-derived MGE neurons to human whole ganglionic eminence cells at 9-18 GW (Shi et al. 2021).</p></caption><graphic xlink:href="EMS207079-f002"/></fig><fig id="F3" position="float"><label>Figure 3</label><caption><title>Cell-type-specific enrichment of schizophrenia GWAS signals in MGE-derived neuronal populations</title><p>A) Annotation of cell types visualized by UMAP. B) Heatmap showing classic progenitor- and neuron-expressed genes in each cluster group. C) Violin plot showing differential expression of MGE neuron genes in each neuronal cluster group. D) Bar plot depicting the –log₁₀(FDR-adjusted p-values) for MAGMA cell-type enrichment tests across the annotated cell types. Two modes of enrichment analysis were tested: linear (red) using all expressed genes, and top 10% (blue) using only the top 10% most specific genes expressed in each cell type. Vertical dashed line marks the significance threshold (FDR = 0.05).</p></caption><graphic xlink:href="EMS207079-f003"/></fig><fig id="F4" position="float"><label>Figure 4</label><caption><title>Preferential effects of 24S, 25-EC on neuronal groups</title><p>A) 24S, 25-EC-dependent fold changes in the proportion of each cluster group. Significance threshold: -0.58&gt;Log2 fold change&gt;0.58, FDR&lt;0.05. B) Heatmap and bar graph showing the number of DEGs of different categories by each cell cluster. C) Pie chart showing GO terms of d25 DEGs of progenitor and later progenitor populations. D) Heatmap showing enrichment of LXRβ target genes in DEGs of different categories and each cell cluster.</p></caption><graphic xlink:href="EMS207079-f004"/></fig><fig id="F5" position="float"><label>Figure 5</label><caption><title>24S, 25-EC promote MGE progenitor neurogenesis via LXR</title><p>A) Outline of the neural differentiation paradigm. B) Bar graph showing % of NKX2.1<sup>+</sup> Ki67<sup>+</sup> cells in d25 cultures treated with vehicle and LXR agonist GW3965 (GW). C) Endogenous mEmerald signal from the LHX6-mEmerald cultures treated with vehicle or GW at d25, d30 and d35. D) Line plot showing the % of mEmerald<sup>+</sup> neurons at d25, d30 and d35. E) Dot plot showing cell cycle exit index of control and GW-treated cultures. F) Double immunostaining for NKX2.1 (green) and Ki67 (light blue) combined with EdU labelling (red.) Arrow heads indicate NKX2.1<sup>+</sup>EdU<sup>+</sup>Ki67<sup>-</sup> cells. G-H) Dot plot showing the portion of NKX2.1<sup>+</sup>EdU<sup>+</sup> and NKX2.1<sup>+</sup>Ki67<sup>+</sup> progenitors, respectively, in isogenic iCas9 control and LXRβ knockout cultures in responding to EC treatment. I) Dot plot showing the quantification of cell cycle exit index in wildtype and LXRβ knockout cultures in response to EC treatment. Data presented are mean ± s.e.m. of three independent differentiation runs, each with 2-3 technical replicates. Each dot in the graphs represents an image counted. The numbers of technical replicates and images counted in B, D, E, G-I are provided in <xref ref-type="supplementary-material" rid="SD1">table S4</xref>. EC treated vs vehicle control groups were compared by Kruskal-Wallis with post-hoc Dunn in B. Two-way ANOVA with post-hoc Bonferroni in D. One-way ANOVA with post-hoc Bonferroni (E,I) or Dunnett T3 when equality of variances criteria was not met in G, H. (*p&lt;0.05; **p&lt;0.01; ***p&lt;0.001). Nuclei were counterstained with DAPI (blue) or Hoechst for live imaging in C. Scale bars: 100 µm.</p></caption><graphic xlink:href="EMS207079-f005"/></fig></floats-group></article>